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ABSTRACT 
Cytokines are small molecular weight glycoproteins secreted by a v;iriety ot" cells. These 
proteins have diverse activities and serve as signal mediators in immune reactions. Among the 
stimulators of cytokine induction, bacteria and their products are well-known. However, the 
regulatory mechanisms of cytokine expression associated with bacterial diseases are 
complicated and not completely elucidated. 
In the first study, mammary parenchymal tissues taken from Holstein cows at 6, 12. and 
24 hours post-challenge with Escherichia coli were used as an acute bacterial infection model. 
In the study, we determined that IL- la and TNF-a were the predominant cytokines expressed 
in mammary parenchymal tissues during the early phase of E. cc//-induced mastitis. In 
contrast to these cytokines, expression of mRNA for IL-ip. lL-6. and IFN'-yin 
£. c6>//-infected mammary gland were low at the time points examined. The second study was 
designed to investigate the effects of CD 18, an adhesion molecule, on cytokine gene 
expression in bovine pulmonary tissues after respiratory infection with Pasteiirella haemolytica. 
This study suggested that CD 18 may contribute to mRNA expression of IFN-yand TNF-a in 
the lung of P. haemolytica-in'lccx.Qd. cattle at 4 hours post-challenge. Based on histological 
evidence, this observation correlated with the infiltration of neutrophils into the lung tissue. 
For the third study, ileal tissues from cattle chronically infected with Mycobacterium avium 
subsp. parauiberculosis were examined for the chronic expression of cytokine-specific mRNA. 
Ileal tissues collected from cattle with paratuberculosis expressed significantly (P<0.05) more 
IL-la. IL-1(3, IL-6 and IFN-ymRNA than paratuberculosis negative cattle. The expression 
level of TNF-a, however, was not different between M. avium subsp. parataberculosis-
infected and non-infected animals. Histologically, the ileal tissues from paratuberculosis 
positive cows harbored 3 times more macrophages than control cattle. 
In combination, these studies suggest that the patterns of cytokine expression and the 
predominant subset of leukocytes in cattle may vary depending on a \ ariety of factors that 
include pathogens, tissues and time after infection. We believe that developing an 
understanding of the role of cytokines in disease can be a step towards controlling infectious 
disease. 
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GENERAL INTRODUCTION 
Dissertation Organization 
The following dissertation is organized into a general introduction, three journal papers and 
a general conclusion. The general introduction is a review of the literature of bacterial infection 
and cytokine functions. The first paper is research conducted to characterize expression of 
selected cytokine genes in Escherichia coli infected mammary gland of Holstein cows. The 
second paper studied cytokine gene expression in associations with the adhesion molecule 
P;-integrin in the lung tissues of Pasteurella hciemolyticci infected cattle. The third paper reports 
cytokine gene expression in Mycubacteriiim parcitiiberciilosis infected bovine ileal tissues. All 
three papers will be submitted to peer-reviewed, scientific journals for publication. 
Literature Review 
Infection and Immune Responses 
Introduction 
Multicellular organisms developed sophisticated control systems during evolution in order 
to maintain homeostasis from various insults. These include bacterial, viral, and parasitic 
infections, as well as trauma, many forms of neoplastic disease, and psychological stress all of 
which elicit a well-characterized series of changes in host metabolism. These may include 
fever, loss of appetite, and lean muscle loss (16. 61, 73). These phenomena are part of the 
acute phase responses (APRs) and are mediated by acute phase cytokines (APCs) such as 
interleukin-1 (IL-1), IL-6, and tumor necrosis factor (TNF) (73. 142). .Acute phase cytokines 
are glycoproteins secreted by a variety of cells, mainly activated macrophages (61. 69). These 
.A.PCs activate immune cells to secrete other immune mediating materials, engulf invading 
foreign substances, neutralize toxins, and to express adhesion molecule that mediate receptor 
binding. In addition, APCs activate endothelial cells to express cell adhesion molecules to 
facilitate immune cell infiltration to the target tissue (22, 100). In severe cases of microbial 
infection or chronic inflammation, local inflammatory reactions are magnified as systemic 
reactions through neuroendocrine system. It is well documented that excessive production of 
APCs induces production of stress hormones such as adrenocorticotropin hormone (ACTH), 
glucagon, adrenocortisone, and neuropeptides such as substance P (27. 61. 73. 141) 
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Gram-negative bacterial infection and acute phase cytokines 
Lipopolysaccharide (LPS), an outer membrane component of Gram-negative bacteria, is a 
potent inducer of immune responses by activating immune cells to proliferate and produce 
cytokines, lipid metabolites and reactive oxygen metabolites (61, 142). Sepsis caused by 
infection of microorganisms or their metabolites is still one of the leading cause of death in 
human (20, 57, 69, 146). A large portion of sepsis is caused by LPS or endotoxin (146). 
Much of the pathophysiology associated with endotoxemia is mediated by APCs (69). 
In response to APCs, the liver decreases the rate of synthesis of selected proteins and 
increases the rate of synthesis of acute phase proteins (APPs) ( 16). In humans, APPs are 
subdivided into 3 groups according to their rate of increase in the plasma; 1) the concentration 
may increase by about 50%, e.g., ceruloplasmin and complement C3 (C3) 2) those which 
increase 200 to 300%, e.g., a 1-acid glycoprotein, a 1-antitrypsin, al-antichymotrypsin. 
haptoglobin, transferrin and fibrinogen, and; 3) a group containing those that may increase as 
much as 1000 fold. Serum amyloid A and C-reactive protein are members of the last group 
(11, 16. 54, 59). The protective functions of C-reactive protein in the acute phase response are 
believed due to activation of the complement cascade, and facilitation of the removal of 
invading bacteria by acting as a nonspecific opsonin (150). Serum amyloid A has been found 
to possess immunoregulatory properties. The protein helps to remove unwanted materials such 
as bacterial endotoxin transported by high-density lipoproteins e.g.. LPS binding protein in 
serum (21. 156). 
The LPS binding protein (LBP) is another serum protein that plays an important role in 
Gram-negative bacterial infection. This protein recognizes serum LPS and forms a LPS-LBP 
complex which binds to cluster of differentiation antigen 14 (CD 14) on immune cells, mainly 
blood monocytes or macrophages. The interaction of the LPS-LBP complex with CD 14 
induces cytokine production and facilitates the adaptation of immune cells to LPS (57. 69. 70. 
85. 148). In the case of Gram-negative bacterial infection, the synthesis of LBP increa.ses 
substantially in the liver (70). The antigen, CD 14 was first considered to be a differentiation 
antigen of myeloid cells. This protein is now considered a high affinity LPS receptor and is 
mainly expressed on peripheral blood monocytes, and to a lesser extend on peripheral blood 
neutrophils (69). Monocytes can be activated by LPS via both CD14-dependent and 
CD14-independent pathways (167). Pathways dependent on CD 14 need much less LPS than 
CD 14-independent pathways to activate LPS-inducible genes (102). Furthermore, the CD14-
dependent pathway activates more genes than the CD 14-independent pathway at high 
concentrations of LPS (102). The antigen, CD 14 is a member of the phosphatidylinositol (PI) 
anchored protein family (69, 76). The mechanism of signal transduction of CD 14 in response 
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to LPS is still unclear since this protein does not contain a traditional transmembrane domain 
(69, 93). Several postulations have been given to explain the participation of CD 14 in LPS 
signal transduction. Internalization of CD 14 by endocytosis has been observed (69, 116). 
Other investigators have postulated that the LPS-CD14 complex needs other cell surface 
molecules to transmit signals into cytoplasm (69, 76). A human major histocompatibility 
complex (MHC) class II antigen receptor, HLA-DR, may function as a secondary co-receptor 
with CD 14 to induce TNF-a production in LPS stimulated cells (105). Another group has 
proposed that L-selectin acts as a low-affmity LPS receptor, at least in neutrophils (83). In 
other experiments, anti-CD 18 antibody and anti-ICAM-I antibody administration prevented 
TNF elevation and acute death in a rabbit injected with a lethal dose of LPS (93). This 
suggests a possible role for P2-integrins in LPS induced signal transduction, at least, as a 
secondary LPS binding receptor (93). 
The genetic background of an individual also influences the response to infection. A study 
that conducted to measure the amount of TNF produced by healthy donors" peripheral blood 
mononuclear cells (PBMC) stimulated with LPS showed that the leukocytes of low responders 
transcribe less TNF mRNA compared to those of high responders (114). The results of other 
studies indicated that hundred fold differences in the amounts of cytokines produced by LPS 
stimulated PBMC from different individuals (45). 
When LPS-LBP binds its cellular receptor, CD 14 or an unknown low affinity receptor, it 
alters the phosphorylation property of cytoplasmic proteins of target cells, resulting in 
downstream signal transduction. The precise mechanism of signal transduction induced by 
LPS in macrophages is not yet known. Several investigators suggested the existence of 
multiple pathways and different regulatory mechanisms for transduction of the LPS signal in 
macrophages (10, 65, 142). It has been observed that LPS and lipid A analogs induce TNF-a 
production in murine macrophages through activation of protein tyrosine kinases (PTKs) (65). 
The PTKs that are involved in the signal transduction of LPS are Src family protein kinases 
and mitogen activated protein (MAP) kinases (10, 65, 142). The importance of PTKs in the 
LPS signal transduction pathway was shown using tyrosine kinases inhibitors. When murine 
macrophages are exposed to tyrosine kinase inhibitors such as herbimycin A, tyrphostin and 
genistein, LPS induced TNF-a and IL-1 production is markedly reduced (10. 65, 142, 167). 
At the same time, tyrosine phosphatase inhibitor, sodium orthovanadate, increases LPS-
induced TNF-a production (10). Recent work, however, provided another view of Src family 
protein kinases involvement in LPS signal transduction. They created a triple mutant strain 
mouse, hck'' fgr'''lyn"'", that lacks all three functionally imponant Src family protein kinases 
(89). Macrophages derived from these triple mutant mice express normal levels of CD 14 and 
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show normal immunological functions (89). The signals activate several types of transcription 
factors, including nuclear factor-kappa B (NF-kB) (93). The activation of transcription factors 
increases the expression of cytokines, cell adhesion molecules and other immunologically 
important proteins (87, 93). Even though these APCs are essential for initiation and 
modulation of healing processes, overexpression or prolonged secretion may deteriorate the 
health of the host by acting as potent mediators of pathogenesis (57. 94). 
Glucocorticoids in immune response 
One of the characteristic responses of the neuroendocrine system to stress and infection is 
modulation of hormonal secretion. Endotoxin treatment induces reduction of thyrotropin 
(TSH) and growth hormone (GH) secretion in rats (112). A variety of cells in the central 
nervous system (CNS), such as microglia, astrocytes, and oligodendrocytes, secrete many 
cytokines and e.xpress various cytokine receptors (64, 108, 138. 145). Immune cells of the 
CNS serve as a source of APCs and the APCs produced by peripheral immune responses also 
influence the CNS (138). 
The peripheral APCs manipulate immune responses by modulating the endocrine and 
nervous systems through the hypothalamic-pituitary-adrenal (HP.A.) axis, while also down-
regulating the pituitary-thyroid and pituitory-gonadal a.xes (64, 145). The peripheral .APCs 
activate the hypothalamus to produce corticotrophin-releasing hormone (CRH) which 
stimulates the anterior lobe of the pituitary gland to excrete ACTH (145). The ACTH acts on 
the adrenal gland to produce stress hormones such as Cortisol and other glucocorticoids (145). 
The immune modulatory effects of hormones, especially adrenal hormones, are well studied. 
Glucocorticoids have a variety of effects on lymphocytes, including induction of apoptosis. 
and repression of cytokine and cytokine receptor expression (177). In a human natural killer 
(NK) cell line (NK3.3) study, Cortisol suppressed expression of perforin mRN.A. granzyme A. 
and adhesion molecules including CD 16, CD2 and CDl la (177). Glucocorticoids can transfer 
their effects by passing through the cell membrane and binding to the cytoplasmic receptor 
(145). The GC-receptor complex displaces heat shock proteins in the cytoplasm and then 
moves into the nucleus. Glucocorticoids modulate immune responses by binding 
glucocorticoid response elements (GREs) that regulate protein synthesis, or by interfering with 
other signal molecules binding to NF-kB binding sites or induction of inhibitor-kB (IkB) 
(145). Preventing leukocyte migration into tissues by down-regulating adhesion molecule 
expression is one anti-inflammatory mechanism induced by glucocorticoids. Dexamethasone 
(Dex). a synthetic GC. down-regulates ICAM-1 expression in LPS or cytokine treated human 
cell lines (8, 100, 168). Glucocorticoids down regulate expression of L-selectin and CD 18 on 
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bovine neutrophils (24). Dexamethasone also functions to down-regulate membrane 
expression of the T cell receptor (TCR)/CD3 complex (90). This may be one of the major 
mechanism of down-regulating immune response since TCR/CD3^ CD4' cells are the major 
helper T cells. 
Stress and anxiety have also been implicated in triggering non-pathologic inflammation (27. 
48, 152). Mast cells in rat dura degranulate during the stress associated with restraint (152). 
.Vlast cells contain several immune mediators including inflammatory cytokines that trigger 
neurological symptoms such as migraines. It was speculated that the degranulation of the dura 
mast cells was stimulated by neuropeptide substance P (SP). secreted by sensory nerve 
endings through the action of CRH (5, 152). It has been known that various neuropeptides are 
involved in immune responses and hormonal regulation (64). Within some tissues, terminal 
nerve endings and immune cells are located side by side, facilitating intracellular cross-talk 
(145). Even though mast cells secrete a variety of cytokines, SP has been shown to selectively 
activate the TNF-a gene in murine mast cells (5). Stress induced release of adrenal hormones 
resulted in increased circulating of neutrophils (40). Stress can induce changes in either the 
expression or affinity of surface adhesion molecules. These stress responses may redirect 
leukocytes to other immune compartments where leukocytes are likely to encounter antigens 
(Ags), pathogens or other activated immune cells (40). 
.\cute Phase Cytokines in Disease 
Tumor necrosis factor (TNF) 
Over a century ago, TNF was originally identified as a mediator of tumor necrosis present 
in the serum of animals that suffered from tumors, leading to the designation of TNF (3, 163. 
165). Originally there were only two members of the TNF family. TNF-a (cachectin) and 
TNF-(3 (lymphotoxin (LT)). Now this superfamily has other members, including LT-(3, 
CD30 ligand (L), CD27L, OX-40L, FasL, 4-lBBL, and TNF-related apoptosis inducing 
ligand (TRAIL) (3) The TNF-a and TNF-P genes are single copy genes, closely linked with 
MHC class III genes (163). Human TNF-a is expressed as a membrane bound protein, then 
secreted as a 157-amino acid polypeptide monomer (17 kDa) by the activity of a TNF-a 
converting enzyme (TACE). TNF-P is a secreted protein consisting of 171 residues with 
molecular weight of 25 kDa (3, 18, 62, 163). Comparison of bovine TNF-a and TNF-P 
amino acid sequence with other species shows 70-90% homology with the murine, rabbit, 
ovine, and human counterparts (32). Even though the proteins are believed to have evolved 
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by tandem repeat, the homology rates between TNF-a and TNF-p within species are only 
25-40% (32). The functional TNF is a conical-shaped trimers composed by three identical 
monomers (44, 62). 
At the cellular level, TNF has been shown to have pleomorphic effects on a variety of cells. 
These abilities place this cytokine in a pivotal role in modulating acute and chronic 
inflammation (3. 163). Tumor necrosis factor is the principal mediator of the host response to 
bacteria, viruses, and other infectious invaders (36. 158). Tumor necrosis factor is also 
responsible for metabolic abnormalities frequently accompanying microbial disease and 
malignant neoplasm (15, 73, 158. 165). Injection of a sub-lethal dose of TNF-a can 
reproduce the same metabolic changes that occur during endotoxemia in many species (15). 
Endotoxin or LPS-activated macrophages have been known to be a major source of TNF. 
although activated T cells, natural killer cells (NK), and mast cells also produce this cytokine 
(3. 73. 163). In early phases of the innate immune respon.se. TNF stimulates surrounding 
cells to express more adhesion molecules and to produce more cytokines to facilitate 
inflammation and phagocytosis of the invading microorganism (3. 88. 158 ). But 
overexpression or prolonged expression can be deleterious and. in some tumors. TNF acts as 
an autocrine or paracrine growth factor (3). 
The importance of TNF in resistance to a variety of infections has been well documented. 
In vitro studies show that TNF protects the host not only from bacterial, but also viral, fungal 
and other infections (3). Injection of anti-TNF antiserum into mice infected with a virulent 
strain of Salmonella typhiniurium enhanced the severity of disease ( 154). .VIoreover. the 
protection achieved by immunization with live attenuated 5. typhiinuriiim was abolished by 
the injection of anti-TNF both in early (3 weeks) and late (10 weeks) immunity trials (154). 
The immunity in the early stages of immunization is mediated by macrophages and in later 
stages by antigen specific T cells (154). The early protective activity of TNF by macrophages 
is a nonspecific "bystander protection" because vaccination can protect mice from a different 
serotype oiSalmonella and a nonrelated intracellular pathogen Lisieria munocyto^enes (154). 
This may explain why the activities of TNF against pathogenic microorganism are exerted 
indirectly through activation of a variety of immune cells. In addition to 
monocytes/macrophages and lymphocytes, mast cells are also a source of TNF. .A.ctually. 
mast cells are the only leukocyte subset which contain preformed TNF-a (82). Experiments 
performed with mast cell deficient mice have demonstrated the critical role of TNF-a 
produced from mast cells in bacterial diseases (43, 82). In another experiment, tumor 
necrosis factor receptor-1 (TNFR-1) deficient mice aLso were very vulnerable to infection by 
Listeria monocytogenes (107). Interestingly, these same mice were resistant to LPS induced 
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toxicity (107). Tumor necrosis factor-a enhances the ability ot'T-cells to clear To.xupUisma 
gondii (101). Granuloma formation in Mycobacterium luberculusis and Schistosoma 
mansoni infection has also been shown to be dependent upon TNF production (28, 29). 
The therapeutic potential of TNF was investigated in a murine mastitis model. Injection of 
TNF-a into the mammary gland resulted in more neuu-ophils recruited during the initial 4 hour 
post-injection than in the control group (111). The increased neutrophil influx facilitated 
remove of S. aureus in mammary gland. Neutrophils treated with TNF-a in vitro have a 
greater microbicidal activity against ingested Staphylococcus aureus than untreated neutrophils 
(110) .  
TNF-receptors (TNFR) 
There are 2 types of tumor necrosis factor receptors (TNFRs). a 55 kDa molecule 
(TNFR-1) and 75 kDa molecule (TNFR-2) (37, 158). Both receptors have very similar 
extracellular portions and contain 4 cysteine rich domains (37. 158, 163). The first and second 
extracellular domains have 6 conserved cysteine residues that are highly homologous between 
the two TNFT?.s (37). Intracellular regions of both TNF receptors are rich in proline and serine 
residues (37). These domains are shared with other proteins such as nerve growth factor 
receptor, CD27, CD30, CD40, Fas, 4-IBB and OX40. The intracellular domains, however, 
are very different from one another (3, 37, 158, 163). For the maximal cellular response, a 
clu.ster of three receptors must bind with a TNF trimmer (158). The intracellular region of 
TNFR family of proteins contain a homologous death domain that triggers signal transduction 
resulting in apoptosis and other immunological functions of the receptor (31. 71. 98, 99). 
In the serum and urine of patients with acute or chronic diseases such as endotoxemia. 
AIDS, cancer and arthritis, extracellular fragments of both TNFR-1 and TNFR-2 have been 
detected. These fragments are called TNF-binding proteins (TNF-BP) or soluble TNF 
receptors (sTNFR) (158). The biological function of these sTNFRs was originally understood 
as an antagonist of excessive amount of biologically active TNF during inflammation. In low 
concentration, sTNFRs prolong the bioavailability of TNF but in higher concentration. 
sTNFRs bind free TNF to reduce the incidence of receptor-ligand binding (157, 158). There is 
controversy over which TNFR is more suitable for blocking TNF mediated pathologic change 
(55). 
The e.xact mechanisms how TNF elicit such a variety of responses as initiation of 
inflammation, necrosis of tumors, proliferation of cells and induction of apoptosis are not 
known yet. Tumor necrosis factor receptor-1 activates two types of sphingomyelinases, a 
neutral sphingomyelinase and an acidic sphingomyelina.ses (169). These two 
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sphingomyelinases use different signaling pathways, one involving protein kinases and 
phospholipase A2 and the other involving activation of NF-kB. this may explain in part, the 
diversity of effects mediated by TNF induced signal transduction (169). One of the proposed 
mechanisms is that TNF activates sphingomyelinases to produce ceramide from cell membrane 
(55, 117). Ceramide has been known to be a key regulator in signal transduction pathway with 
diverse effects upon cell cycle regulation, apoptosis, and cellular senescence (55, 151). 
Interleukin-1 (IL-1) 
Interleukin-1 (IL-1) mediates a wide range of biological activities including 
immunoregulation, inflammation, and hematopoietic activities (42, 97). Interleukin-1 has been 
referred to by a variety of other names such as endogenous pyrogen, hemopoietin-1 and 
canabolin because of the protein's wide range of physiological activities (6, 73). Endotoxin 
and TNF are known to be potent inducers of IL-1 production (45). Although the primary 
source of IL-1 is activated macrophages, a variety of cells including lymphocytes, neutrophils, 
fibroblasts and keratinocytes produce the cytokine (6, 25. 35, 73). 
IL-l contains two members, IL-1 a and IL-1 (3, which are encoded by separate genes (6). 
Both proteins are synthesized as inactive 31 kDa precursors (pro-ILl) and processed to 17.5 
kDa active mature proteins by enzymatic cleavage of 100 amino acids. The enzyme catalyzing 
this cleavage is interleukin-1(3 converting enzyme (ICE or caspase-1) (6, 25, 61, 73, 108). 
Because of this unusual process and cleavage, there are two biologically active forms of IL-1, a 
secreted form (mostly IL-1[3) and acell-bound form (mostly IL-la) (6, 41, 73). At the amino 
acid sequence level, IL-la and IL-1 (3 share about 80% homology with other mammalian 
species (94). Within a species IL-la and IL-lp share only about 25% homology, however, 
the three-dimensional structural similarity of the proteins allow them to share the same 
receptors (41, 94). Both IL-la and IL-ip bind to the same receptors with similar affinity and 
transduce similar functions (6, 73). Even though the genes are encoded separately, there is a 
correlation between production of IL-la and IL-1 (3 in LPS treated human PBMC culture (45). 
There are many regulatory activities that overlap between lL-1 and TNF. however the 
lymphocyte proliferation effect of IL-1 distinguishes this protein from TNF (159). 
Administration of recombinant bovine IL-ip (rbIL-l(3) induces an increase of body 
temperature, circulating leukocytes, and APPs including haptoglobin and tlbronectin (52). At 
the same time, IL-1 administration decreases plasma zinc (52). Most immune modulatory 
functions of IL-1 are manifested by activation of T lymphocytes, resulting in increased IL-2 
production, induction of IL-2 receptors on T cells, stimulation of B cell proliferation and 
differentiation, and stimulation of thymocytes (6, 41, 73, 139). .Moreover, IL-1 costimulates 
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the proliferation of immature progenitor ceils to proliferate in bone marrow in response to 
macrophage-colony stimulating factor (M-CSF) and IL-3 (6). IL-I is a potent stimulator of 
arachidonic acid metabolism (35). The metabolites of cyclooxygenase are prostaglandins that 
induce fever, vascular permeability, and edema (35, 41). The products of lipoxygenase are 
leukotrienes that mediate chemotaxis, vasoconstriction and aggregation of cells (35). 
Interleukin-1 increases the rate of protein degradation by a mechanism mediated by 
prostaglandin E2 (PGE2) (53). Elevated PGE2 is thought to increase intracellular Ca-+ ion 
levels, which in turn induce lysosomal enzyme release (53). 
Interleukin-1 is known to be produced in the bovine mammary gland in response to LPS 
infusion or Escherichia coli induced mastitis (126). Interleukin-1 increases vascular 
permeability allowing serum proteins to diffuse into the mammary gland. In a swine study, 
pigs challenged with Streptococcus suis in conjunction with rblL-lp (10 jig/kg) for 3 
consecutive days shown higher antibody titer, less mortality, better growth performance and 
less severe pathological signs than control animals challenged 5. suis without rblL-lp (19). 
Pretreatment of bovine neutrophils with recombinant human IL-iP (rhIL-I(3) increases the 
activity of neutrophils to kill Staphylococcus aureus (110). These immunological benefits of 
rIL-ip may be associated with the non-specific immune enhancing effects of the cytokine. 
.After treating with rIL-ip. neonatal piglets showed increased innate immunity such as higher 
counts of leukocytes, especially CDS'' lymphocytes and neutrophils along with an increased 
titer of antibody (19, 121). Furthermore, IL-1 treatment enhances the leukocyte-endothelial 
cell adhesion and expression and production of other adhesion mediating proteins such as 
integrins on the surface of endothelial cells (13. 14, 17, 84). 
One of the anti-inflammatory agents that suppress production of lL-1 is glucocorticoids. 
The existence of a complete regulatory loop between IL-1 and glucocorticoids is well 
characterized. Interleukin-1 increases the secretion of glucocorticoids while glucocorticoids 
depress the release of IL-1 from macrophages in a negative-feedback control system ( 132, 
165). Other important roles for IL-1 in an immune response include the activation of 
hepatocytes and the expression of APPs (6). The functions may. however, be e.xeried through 
production of IL-6. 
IL-1 receptors (IL-IR) 
The biological functions of IL-1 are mediated by distinct, specific high-affinity cell 
receptors that are expressed on virtually all cell types. Interleukin-1 receptors (IL-1 Rs) are 
single strand proteins that contain two members, type I and type II IL-lRs. Amino acid 
sequence shows that both receptors consist of a single transmembrane domain, an intracellular 
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domain, and three immunoglobulin like extracellular ligand binding domains. Because of these 
characteristics, these receptors are classified as members of the immunogiobulin-like receptor 
family (61,91). Type IIL-IR has an 80 kDa molecular mass and is the predominant form on 
T cells and fibroblasts, whereas B cells, monocytes, neutrophils, and bone marrow cells 
express the type II receptor (60 kDa) as the major receptor (61, 86, 129, 131). A distinct 
difference between type I and II receptors is the length of the cytosolic domain. The cytosolic 
domain of the type I receptor consists of 215 amino acids, this is long enough to possess 
intrinsic enzyme activity or protein binding activity, whereas the type II receptor has only 29 
amino acid residues (61,86, 131). Therefore, the biological activities of IL-1 are mediated by 
binding to IL-IR type I, but not IL-IR type II (61, 131). It is believed that the truncated 
intracellular domain of EL-IR type II results in loss of its signal transduction activity and serves 
as a functional decoy by removing excessive IL-1 (34,61. 130, 131. 147). Another important 
regulator of IL-1 activity. IL-1 receptor antagonist (IL-lRa). has been described (61). This 
antagonist binds IL-IR type I with an high affinity but not to IL-IR type II (61). The 
antagonist effect of IL-lRa was proved in an endotoxin challenge mastitis study (124). 
Recombinant human IL-lRa completely prevents the activity of IL-1 in whey secreted from 
mammary glands infused with endotoxin and four doses of rhIL-IRa at 0. 4. 8. and 12 hour 
post-infusion, but failed to suppress local and systemic inflammation (124). This may the 
result of the ineffectiveness of rhEL-lRa in the bovine system, the suppressive effects of milk 
on rIL-1 Ra, or simply the activities of other APCs such as TNF and IL-6. Interleukin-1 Ra or 
sTNFR can block the activity of either IL-1 or TNF. respectively, but can not reduce 
inflammation caused by endotoxin or infections (49). In other experiment, administration of 
IL-lRa relieved tissue injury in an ischemic rat liver (122). 
Interleukin-1 and TNF expression is dependent on signal transduction via protein kinase C 
(120). Even though IL-IR is a member of the Ig-like receptor family, its cytosolic domain has 
features similar to the cytokine receptor superfamily (CRS) (75). Like other CRS receptors, 
the cytosolic regions of the IL-lRs do not have their own protein kina.se activity (75). 
Interleukin-1 uses 1.2-diacylglycerol (DAG) and ceramide as second me.s.senger molecules in 
signal transduction with TNF (117). The box 1 and box 2 like elements in the cytosolic 
domain of the CRS are essential for the Janus kinase (JAK) activation of the cytokines (60, 
160, 170). The cytokine receptor superfamily includes the receptors of growth hormone 
(GH). prolactin (PRL), erythropoietin (EPO), leukemia inhibitory factor (LIF). ciliarv' 
neurotropic factor (CNF), granulocyte monocyte colony stimulating factor (GM-CSF). 
granulocyte colony stimulating factor (G-CSF), oncostatin M (OSM). interferon a, (3, and y 
(IFN-a, (3, and y), and IL-2, 3, 4, 5, and 6 (60. 170). A JAK induces autophosphorylation 
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and transphosphoryiation of receptor, signal transducers and activators of transcription 
(STAT), and other cellular substrates (.60, 170). For transmembrane signaling, dimerization or 
oligomerization is essential to generating complexes that bind and activate intracellular, 
nonreceptor tyrosine kinases (7, 56, 166, 171). The CRS has conserved cysteine residues and 
a unique WSXWS motif in its extracellular domain. This Trp-Ser-X-Trp-Ser motif near the 
transmembrane portion is essential for protein folding, ligand binding and signal transduction 
of the cytokines (164). 
Interieukin-6 (IL-6) 
Even though IL-6 is one of the APCs, the role of IL-6 is more anti-inflammatory rather 
than proinflammatory due to its ability to antagonize the effects of IL-1 and TNF (79, 94. 149. 
153, 172). This may be related to the ability of IL-6 to skew the immune response towards 
humoral rather than cell mediated immunity (79). Interleukin-6 is produced as a single chain 
glycoprotein by most cell types including T cells, macrophages and fibroblasts, and has a 
molecular mass between 23 and 30 kDa (6, 12, 79, 100. 118. 140, 162). The various sources 
of this protein and post-translational modification such as glycosylation contribute to the 
heterogeneity of this protein, however, the biological activity of the proteins are basically same 
(128). Like other APCs. IL-6 production can be induced by LPS and other cytokines, 
including TNF and IL-l (12, 79, 118). Treatment of human thymic epithelial cells with LPS, 
TNF-a or IL-l[3 increases IL-6 production (33). Maximal induction was reached after 1-3 
days of exposure and some synergy between stimuli was noted (33). The treatments not only 
increased the amounts of cytoplasmic IL-6 mRNA per cell but also increased the number of 
cells expressing IL-6 (33). Interleukin-6 expression and secretion are inhibited by 
glucocorticoids, retinoic acid and other cytokines that include lL-4 and IL-10 (79). 
Before the IL-6 nomenclature was established, the protein had a variety o^" names according 
to it's functions that were discovered in different research systems, such as interferon-P,, 
B-cell stimulatory factor 2, hybridoma growth factor, plasmacytoma growth factor, hepatocyte 
stimulatory factor, hematopoietic factor, and cytotoxic T-cell differentiation factor (9, 73, 94, 
128. 140). As the old names imply, IL-6 is a multifunctional cytokine and involved in B cell 
proliferation, APP production in hepatocytes, hematopoietic cell growth, and differentiation of 
certain myeloid leukemia cell lines (6, 79, 140, 155, 162). The function of IL-6 to stimulate 
the hematopoietic system makes the cytokine a good candidate as a therapeutic agent after 
chemotherapy of cancer patients (162). IL-6 shares similar sequences with G-CSF, OSM, and 
LIF at the gene level and also shares a common receptor subunit (6. 94). IL-6 has been known 
to be involved in many diseases such as multiple myeloma, rheumatoid arthritis, castleman's 
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disease, mesangial proliferative glomerulonephritis, psoriasis, sepsis, and osteoporosis (79. 
128). This cytokine is also closely involved in communication between the nervous system 
and the immune system (77, 94). 
[nterleukin-6 plays a role in down-regulating inflammation, as shown by studies using IL-6 
deficient mice who have higher circulating levels ofTNF-a, macrophage inflammatory 
protein-2 (MIP-2), GM-CSF, and IFN-y following LPS injection than wild type mice (172). 
Interleuldn-6 deficient mice e.xperience a higher mortality rate in models of endotoxemia (172). 
IL-6 antagonizes the mycobacteriostatic effect of TNF-a in Mycobaaerium avium infected 
human macrophages (12, 39). This antagonistic effect is exerted by downregulation of TNFR 
expression by IL-6 (12). Treatment with IL-6 alone also increased the intracellular growth of 
M. avium in infected macrophages (39). Mycobacterial infection apparently induces IL-6 
production in murine and human macrophage cultures (12. 149. 161). This enhanced 
production of IL-6 was not observed in macrophages infected with other intracellular bacteria 
(161). In humans, IL-6 administration induced increased levels of IL-IRa and sTNFRl in 
circulation (153). 
Interleukin-6 is usually bound at low affinity by a soluble receptor (118). Lymphocytes of 
healthy humans express undetectable level of IL-6R. in contrast, monocytes of the same 
individuals express high level of IL-6R (9). When the monocytes mature into macrophages. 
IL-6R mRNA expression is down-regulated (9). 
IL-6 Receptor (IL-6R) 
The IL-6 receptor (IL-6R) is composed of two subunits. the ligand specific binding 
a-subunit (80 kDa) and the signal transducing common P-subunit (6. 79. 91. 118. 128). The 
common (3-subunit, gpl30, is also shared by other members of IL-6R family such as LIF. 
OSM. and IL-11 (79, 81, 118, 128, 164). The external domain IL-6R has homology with the 
immunoglobulin superfamily (6). Characteristics of this receptor family include conserved 
.N-terminal cysteines and a C-terminal "WSXWS" motif (128). Soluble IL-6R functions as a 
stimulatory rather than inhibitory as sTNFRs or sIL-lR (128). 
Interferon-y (IFN-y) 
Among the family of interferon proteins, IFN-y is known as immune IFN and exclusively 
p r o duced by T lymphocytes or large granular lymphocytes (LGL or natural killer cells. NK) in 
response to antigenic or mitogenic stimuli (46, 47. 72, 113, 174. 175). This protein consists 
of 143 amino acids and the gene is encoded on human chromosome 12 (46, 47, 103). The 
mature protein has a 17 kDa molecular mass and forms a homodimer under normal 
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physiological conditions (47). The main function of IFN-y is priming monocytes and 
macrophages to promote phagocytosis of microorganism and enhance production of cellular 
mediators such as TNF (47, 105). In contrast to IL-6, this protein skews immune responses 
toward cell-mediated immunity (80, 113). Interferon-y counter-regulates and controls immune 
response toward either Thl or Th2 type reaction by harmonizing with TNF, IL-1, IL-4 and 
IL-10 (28, 29, 47, 80). This cytokine also induces expression of other proteins such as MHC, 
ICAM, CD64 and CC-chemokines (47, 115). The LGLs participate in innate immune function 
and the first immune cell subset produce IFN-y in infection (175). The LGLs are a subset of 
lymphocytes that are categorized as non-B, non-T cells because of a lack of functional B or T 
cell receptors. This cell type only needs one stimulatory signal to produce IFN-y compared to 
the two signals needed by T cells (175). 
Interferon-y has profound immunomodulatory activities (106). Treatment with IFN-y 
enhances bovine neutrophil functions such as antibody-dependent and antibody-independent 
neutrophil-mediated cytotoxicity, bacterial phagocytosis, leukotriene B4 synthesis, and reactive 
oxidative metabolite synthesis (23, 26, 109, 134, 143, 144). The immunomodulatory effects 
of IFN-y are synergistic with TNF-a and more effective in immunosuppressed cattle than 
healthy animals (23, 30, 106). The immunomodulatory effects of IFN-y were also effective in 
bovine monocytes and T lymphocytes (104, 176). 
Most cells have IFN-y receptors, however, the main cell types that respond to the protein 
are macrophages and neutrophils (47, 103). Functional IFN-y receptor has a heterodimer 
structure with molecular mass of 105-130 kDa (46, 47, 103). 
Cytokines in Bovine Diseases 
Dairy cows suffer from a variety of bacterial infections (4, 63, 95, 125). Inflammation is a 
natural reaction to combat infection and is mediated by intercellular signal molecules known as 
cytokines, which include tumor necrosis factor (TNF), interleukin-1 (IL-1). IL-6. and IFN-y 
(4, 68, 74, 94, 123, 125, 126). The role of cytokines in the regulation of infection is very 
complicated and not completely understood. Cytokines can be subdivided as Thl and Th2 
types. Cytokines of the Thl type include IL-1, IL-2, IFN-y, and TNF in contrast Th2 type 
cytokines include IL-4, lL-5, and IL-6 (92). Usually, Thl cells function to prime or activate 
phagocytic cells by producing cytokines (58). Even though it is believed that Th 1 cytokines 
have a vital role in acute infection both cytokine subsets are necessary for immunity (38. 173). 
Moreover, overexpression or prolonged expression of inflammatory cytokines exacerbate 
tissue damage (78, 94). 
14  
Mammary epithelial cells from noninfected cows express cytokine genes that include 
IL-la, IL-ip, IL-6. and TNF-a (96). At the protein level, there is no detectable IL-6 activity 
in noninfected cows (95). The production of cytokines coincides or precedes the development 
of clinical signs such as inflammation, systemic reaction, and hypogalactia (125). Gram-
negative bacterial infections are associated with high levels of IL-1, IFN-y, and TNF-a (95). 
Interleukin-1 and TNF are potent inducers of IL-6 production and the role of IL-6 is more anti­
inflammatory rather than proinflammatory by antagonizing the effects of IL-1 and TNF (12, 
79, 118). Therefore, the kinetics of IL-6 expression is different from proinflammatory 
cytokines even though IL-6 is classified as an acute phase cytokine. 
Immune suppression during the periparturient period contributes to high incidence of 
mastitis (119, 127, 137). Prophylactic use of recombinant bovine cytokines has been studied 
to prevent mastitis. Systemic administration of IFN-y enhances immune activities of T cells 
(104). Cows that treated with intramammary infusion of IFN-y have fewer infection, lower 
clinical signs, and shorter infection period than control animals (133). The effects of IFN-y 
administration may be contributed by enhanced activity of mammary gland neutrophils and 
reduced production of TNF-a by monocytes in mammary glands ( 134-136). Administration 
of granulocyte colony stimulatory factor increased not only the number of neutrophils but also 
the activity of neutrophils to remove pathogens in dairy cows (67. 68). Intramuscular injection 
of IL-1 (3 upregulates transcription of IL-1[3 mRNA (139). Infusion of recombinant human 
IL-lRa prevents bioactivity of IL-1 in milk from endotoxin infused mammary glands (124). 
In chronic M. panitiiberciilosis infection of cattle, monocytes secrete 10 times more IL-I 
than monocytes derived from healthy animals (1,2). The extensive cytokine production leads 
to granuloma formation with chronic inflammation (1.2). .A.lso. IFN-y secreted from T cells 
primes macrophages to secrete other cytokines, engulf more mycobacteria, and kill ingested 
mycobacteria by nitrogen intermediates (50. 51). Macrophages pretreated with IF^-yare 
resistant to subsequent infection with mycobacterial infection but IL-4 and TNF treatment have 
no effects to inhibit mycobacterial growth (50. 51. 66). However, macrophages that are 
infected with mycobacteria suppress bacilli growth in response to IL-4 (38. 50, 51). These 
results imply that the timing of cytokine action is very crucial to the effect of the immunological 
modulators. 
To improve the quality of dairy product and reduce the cost of dairy farmers, more research 
is needed. If we can identify the exact kinetics, site and source of cytokines, we can treat 
inflammatory symptoms more cost-efficiently and develop new types of therapy. 
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Abstract 
Mastitis caused by Escherichia coli is a major problem for dairy cows and can even occur 
on well-managed commercial dairy farms. An efficient and rapid inflammatory response is 
crucial for rapid resolution of coliform mastitis but prolonged or excessive production of acute 
phase cytokines may exacerbate clinical symptoms of the disease. In order to better understand 
the pathogenesis of coliform mastitis and the production of acute phase cytokines in the 
mammary gland we conducted a series of experiments using in situ hybridization techniques on 
tissues obtained from inflamed mammary tissues. Cows were challenged with -30 cfu of 
E. coli strain 487 in one quarter of the mammary gland and parenchymal tissues were collected 
at 6. 12, and 24 h post-challenge. The challenged quarters served as mild mastitic tissues 
while unchallenged contra-lateral quarters served as negative control tissues. Mammary gland 
tissues obtained from cows with naturally-occurring, coliform mastitis ser\'ed as a model for 
severe mastitis. Tissues were subjected to in situ hybridization using probes for interleukin-la 
(IL-la), IL-1(3, IL-6, interferon-Y(,IFN-y), tumor necrosis factor-a (TNF-a) and a 
housekeeping gene, P-actin (P-Act). Experimentally infected animals showed signs of 
coliform mastitis including increased rectal temperature, somatic cell count, bacteria shedding, 
and TNF-a in milk of challenged quarters. Levels of mRNA expression in mammary tissues 
for all cytokines studied increased as the mastitis episode progressed. Induction of IL-la and 
TNF-a mRNA were higher in tissues both with mild and severe mastitis than the other 
cytokines. Interleukin-ip, IL-6 and IFN-y mRNA expression in the mild mastitic tissues, 
however, were less than 50% of that of the severe mastitic tissues. These results suggest that, 
in coliform mastitis, IL-la and TNF-a may be the pivotal cytokines inducing inflammation of 
infected mammary glands. 
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Introduction 
Mastitis is a major concern for dairy fanners because cows with mastitis not only develop 
hypogalactia but may also die in severe cases (I, 10, 20, 26). Infectious mastitis is caused by 
a variety of microorganisms. Among them, coliform bacteria and streptococci are important (1, 
5. 11). One study performed in England and Wales showed that 422 cases out of 470 Gram-
negative bovine mastitis cases were due to Escherichia culi infection (3). Even though E. culi 
infections are easily controlled by the defense mechanisms in the mammary gland, the 
detrimental effects of the associated endotoxemia are significant to infected cows (1). 
Conventional control methods such as vaccination, pre-milking and post-milking sanitization. 
and intramammary devices have been tried to prevent E. coli mastitis, but none of these has 
been completely satisfactory (I, 10). 
After £. coli infects the mammary gland the bacteria proliferate exponentially and reach 
peak bacterid numbers 10-14 h post-infection (26). The toxins that incite infiammation include 
endotoxin and the immune response mediators such as acute phase cytokines (APCs) which 
include tumor necrosis factor (TNF), interleukin-l (IL-1). IL-6. and lFN-7( 1, 14. 16. 19. 24. 
26, 27). Frost and Brooker found that an inflammatory reaction is critical to cure mastitis and 
also facilitates recovery from disease (7). However, overexpression of inflammatory cytokines 
may exacerbate tissue damage. These cytokines are mainly produced by macrophages and 
other leukocytes but it is not yet clear, in the case of mastitis, which cells produce cytokines in 
the mammary gland. A more thorough understanding of the cellular origin of the acute phase 
cytokines produced during E. culi mastitis may enable better treatment modalities. The 
objective of this study was to identify the cellular origin of acute phase cytokines in the 
mammary gland using in situ hybridization against selected cytokines. 
Materials and Methods 
Animals and Escherichia, coli inoculation 
Six Holstein cows were challenged in the right front (RF) quarter after the morning milking 
with 30 colony forming units (CFU) of £. coli strain MacDonald 487 in 2 ml pyrogen free 
saline. The left front (LF) quarter was infused with 2 ml pyrogen free saline and served as a 
non-infected control. Two animals at 6, 12 and 24 hours post-challenge (PC) were euthanized 
and mammary parenchymal tissues were collected and fixed in neutral buffered 10% zinc 
formalin for histological preparation. 
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Formalin-fixed mammary gland tissues collected from seven Holstein cows with severe 
clinical coliform mastitis were also obtained from the Depanment of Veterinary Pathology at 
Iowa State University, Ames, Iowa. These tissues were used to develop the in situ 
hybridization procedure and provided information on APC gene expression in mammar>' gland 
tissues from cows with ultimately fatal cases of coliform mastitis. 
.\naiysis of milk samples 
Quarter milk and blood samples were collected and rectal temperatures were measured 
every 2 h up to 12 h PC and final samples were obtained prior to euthanasia. Milk was used 
for somatic cell count (SCC) analysis, whey preparation, and bacteriology. Serum was 
collected after centrifugation of blood. Milk samples were preserved with bronopol and sent to 
an independent laboratory (AgSource Milk Analysis Laboratory. Menomonie, WI) for 
electronic analysis of milk composition and SCC. Tumor necrosis factor concentration in 
whey samples was measured as described (27). To measure kinetics of bacterial growth, a 
portion of milk from E. coli challenged glands was plated onto duplicate blood agar plates after 
ten-fold serial dilutions. 
Probe synthesis for in situ hybridization 
Bovine sequence specific RNA probes for five different APCs. interleukin-la (IL-la), 
IL-ip, IL-6, interferon-Y(IFN-v), tumor necrosis factor-a (TNF-a) and a house-keeping 
gene, beta-actin (P-Act) were synthesized. Briefly, cDNA was reverse transcribed from 
bovine leukocyte total RNA using random hexameric primers and subjected to PCR 
amplification using probe specific primer pairs (Table 1). 
The amplified DNA fragments of 156. 180, 201, 250. 119, and 80 base pairs for IL-la, 
IL-ip, IL-6, IFN-y, TNF-a and P-Act respectively, were cloned into a pGEM4 vector 
(Promega, Madison, WI), transformed into E. coli strain JM109. and their sequences were 
confirmed by dideoxy sequencing. For riboprobe synthesis, plasmid DNA was isolated and 
linearized with either EcoR \ or Himllll restriction endonucleases, for antisen.se or sense strand 
probe, respectively. The linear plasmid DNA was transcribed in vitro using either T7 or SP6 
RNA polymerase with ATP, CTP, GTP and digoxigenin labeled UTP (Boehringer Mannheim, 
Indianapolis. IN) as a labeling agent for antisense and sen.se strand probe respectively. The 
antisense strand probe was used for detection of gene expression because it hybridizes with 
mRNA by forming a complementary double strand. The sense strand probe was used as a 
negative control to assess non-specific binding. 
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Table 1. Sequence of oligomers used for polymerase chain reaction amplification of bovine 
cytokine specific cDNA fragments used for synthesis of riboprobes. 
IL-la forward primer 5'- GCGAATTCACAGCAGTTGGAATAAGCCGTG -3' 
IL- la backward primer 5'- CCAAGCTTGCACAGAGTTGGACATGACTGAAG -3" 
IL-13 forward primer 5'- GCGAATTCAAGGCTCTCCACCTCCT(7rC -3' 
IL-1P backward primer 5'- CCAAGCTTGTCTACTTCCTCCAGATGCA -3" 
IL-6 forward primer 5'- GCGAATTCTGGGTTCAATCAGGCGATTTG -3" 
IL-6 backward primer 5'- CCAAGCTTAGGTCAGTGTTTGTGGCTGGAGTG -3' 
IFN-y forward primer 5'- GCGAATTCTTACTGCTCTGTGGGCTTTTGG -3' 
IFN-y backward primer 5'-CCAAGCITTGCrCCl"lTGAAlGACCTGG'n AIC -3' 
TNF-a forward primer 5'- GCGAATTCAAGCCCTGGTACGAACCCATCTAC -3' 
TNF-a backward primer 5'- CCAAGCTTTAGACCTGCCCAGACTCAGCATAG -3' 
P-Act forward primer 5'- GCGAATTCCTGTCCACCTTCCAGCAGATGT -3' 
P-Act backward primer 5'- CCAAGCTTTTCGAAAACGCCACCTGTTACC -3' 
In situ hybridization 
Paraffin-embedded tissue sections were deparaffinized and treated with 10 jig/ml proteinase 
K (Boehringer Mannheim, Indianapolis, IN) for 30 minutes at 37° C. After washing slides 
with diethyl pyrocarbonate (DEPC, Sigma, St. Louis, MO) treated phosphate buffered saline, 
slides were dried. Fifty ill of RNA probe (0.5 mg of RN.A/ml) in hybridization solution (50% 
formamide, 159c DEPC-H,0, 3 X sodium chloride/sodium citrate. 1 X Denhardt's solution, 
0.2 mg/ml yeast tRNA, 50 mM sodium phosphate. pH 7.4 and 10*^ de.\tran sulfate] was 
applied onto a sample slide and covered with a coverslip. Slides were heated at 90° C for 10 
minutes and were hybridized 16 hours in a humidified chamber at 60° C. To remove unbound 
probe, slides were incubated for 30 minutes at 37° C with RNase A (20 mg/ml, Boehringer 
Mannheim, Indianapolis, IN), washed sequentially in 2 X SSC. IX SSC for 5 minutes each 
and 0.5 X SSC for 1 hour at 60° C, and finally with 0.5 X SSC for 5 minutes at room 
temperature. Slides were then incubated with sheep anti-digo.\igenin antibody labeled with 
alkaline phosphatase and developed in 5-bromo-4-chloro-3-indolylphosphate/nitro-blue 
tetrazolium (NBT/BCIP. Boehringer Mannheim, Indianapolis, IN) solution in the dark for 
18 hours. After chromogen development, slides were counter-stained with nuclear fast red for 
3 minutes and coverslips were mounted with aqueous mounting media (Accurate Chemical & 
Scientific Corp, Westbury, NY) (2). 
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Data analysis 
Two scoring systems were applied to 5 independent tlelds on each slide. The first 
assessment was to evaluate the level of gene expression on a per cell basis. Subjective scoring 
of signal intensity was scaled according to the color reaction: 0 = no chromogen staining; 1 = 
pale blue; 2 = blue to purple; 3 = dark purple. Another criterion for the scoring system was the 
percentage of positive cells identified in the first evaluation. Subjective scoring of positive cells 
was as follows: 0 = no positive cells; 1 = 1-30% of cells positive; 2 = 30% to 70% positive 
cells; 3 = > 70% of cells positive. The mean of each slide was calculated from 5 independent 
observations in a given sample. The mean of a given group was an average of the individual 
tissue mean with standard error of mean. An ANOVA test was used to evaluate the effects of 
E. coli inoculation on the e.x.pression of the APC genes in comparison to negative control 
tissues from the unchallenged contralateral quaner. 
Results 
Cows experimentally challenged with E. coli developed mild mastitis with fever 
(Figure I). After 6 h PC (Figure 2), E. coli began rapid growth that was actually preceded by 
an increase in SCC (Figure 3). Presence of TNF-a in whey paralleled this accumulation of 
leukocytes in the milk (Figure 4). .Milk production of challenged glands was reduced 
dramatically at 12 h PC. Challenged glands showed signs of inflammation, including warm 
and swollen glands by 6 h PC. At necropsy the challenged glands were erv'themic, 
hemorrhagic, and had visible milk clots in lactiferous sinuses and milk ducts. Supramammar>' 
lymph nodes from the challenged side of the mammary gland were enlarged in comparison to 
contralateral supramammary lymph nodes. Parenchymal tissues of the challenged glands were 
infiltrated by leukocytes in lactiferous sinuses and milk ducts (Figure 5 and 6). In mild mastitis 
20 to 40% of the parenchymal tissues were infiltrated by leukocytes but in severe mastitis more 
than 50% parenchymal tissues were infiltrated by leukocytes. 
Differences of cytokine gene expression from parenchymal tissues of different disea.se 
states were detected (Figures 5 and 6). Hybridization with sense strand probes failed to detect 
cytokine specific mRNA expression. Mammary tissues from cows with severe coliform 
mastitis had regions of tissue necrosis in which cytokines and P-Act gene expression were not 
detectable. Inflamed tissues adjacent to necrotic regions retained recognizable histological 
architecture and were found to intensely express mRNA of all cytokines tested (Figures 5 and 
6). In these regions circumferential to necrotic tissues, greater than 70% of the cells were 
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expressing APC genes and the level of expression was the greatest in tissues adjacent to 
necrotic tissues (Figures 5 and 6). 
Cows experimentally challenged with E. coli exhibited mild to barely detectable episodes of 
coliform mastitis. Barely detectable clinical evidence of inflammation was particularly true of 
secretions obtained from cows euthanized 6 and 12 h PC. In these tissues, there were regions 
of mammary parenchyma with clearly recognizable mammary histology of milk alveoli and 
collecting ducts. Adjacent to apparently healthy lobules of mammary were dense infiltrates of 
leukocytes that expressed mRNA of cytokines evaluated with moderate intensity (Figures 5 and 
6). iVormal mammary tissues (alveolar epithelial cells) from the unchallenged glands were 
labeled by probe for IL-la (Figure 5). Normal tissues exhibited no detectable basal expression 
of IL-lp and IFN-y, yet these cytokines were expressed in tissues of glands challenged with E. 
coli as early as 6 h after infection (Figures 6 and 7). A high number of cells exhibited low level 
expression of IL-la and TNF-a under conditions of apparently normal health (Figure 8). 
Staining intensity of all cytokines in cells was increased at 6 h PC in mammary glands 
challenged with E. coli (Figure 7). Some cytokine specific mRNA continued to increase 
throughout the 24 h period during which the study was carried out (Figure 7). Tumor necrosis 
factor-a and LL-la stained most intensely suggesting the greatest levels of mRNA compared 
with the other APCs tested (Figure 7). The intensity of staining of the various APCs in 
experimentally challenged cows was only 50 to 70% of the APC in mRNA levels observed in 
tissues obtained from cows submitted to the diagnostic lab (Figure 9). A similar pattern 
emerged regarding the proportion of cells involved with APC gene expression (Figure 10). In 
mild mastitic tissues, the number of TNF-a gene expressing cells was almost the same as that 
of severe mastitis parenchymal tissues (Figure 10). The number of cells that expressed IL-1(3 
or IL-6, however, were very low in mild mastitic parenchymal tissues compare to IL-la, 
IFN-y and TNF-a expressing cells (Figure 10). In severe mastitic tissues, the proportion of 
cells that expressed each cytokine was almost the same (Figure 10). The proportion of cells 
expressing IL-l and lL-6 and the intensity of labeling per cell for these cytokines appears 
correlated with disease severity (Figures 9 and 10). 
Discussion 
Coliform bacteria are the single most common etiologic agent isolated from clinically severe 
mastitis cases on well managed dairy farms. The pathogenesis and severity of the mastitis are 
believed to be related to production of APCs. We established an E. coli infection of the 
mammary gland in this experiment. At necropsy, tissue edema and enlargement of the draining 
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supramammary lymph node was observed. Growth of E. coli and a concomitant increase in 
see was consistent with previous repons (12, 15). The SCC measured from milk of non-
challenged gland showed no significant change during the e.vperiment. Somatic cells are 
composed of leukocytes and epithelial cells. Neutrophils in conjunction with humoral factors 
in milk are the main factors involved with phagocytosis and killing of invading bacteria (11. 
12j. When bacteria enter the mammary gland, the SCC increases because of the transmigration 
of neutrophils from the circulation. This infiltration is regulated by cytokines and chemokines 
produced in the affected tissue (6, 8, 12, 15, 22, 24, 26, 27). 
Endotoxin, a Gram-negative bacterial outer membrane component, has been known to be a 
potent inducer of immune responses by activating immune cells to proliferate and produce 
immune mediators such as APCs. lipid metabolites and reactive oxygen metabolites (9. 30). 
Expression of cytokine genes, IL-la, IL-ip, IL-6, and TNF-a, was detected in cryopreserved 
bovine mammary epithelial cells (21). The production of APCs coincides or precedes the 
development of inflammation, fever, and hypogalactia (26). We detected TNF-a activity in 
whey of £. coli challenged glands. Consistent with previous reports, whey samples from 
non-challenged glands revealed basal level of TNF-a activity and is also consistent with our 
findings of a basal level of mRNA from the TNF-a gene (20). Parenchymal tissues of non-
challenged glands expressed the TNF-a gene constitutively and the number of cells expressing 
TNF-a were higher than for other cytokines. While the E. culi infection progressed, 
expression level of TNF-a and the number of cells expressing the gene increased. In mild 
mastitic parenchymal tissues, the number of cells expressing TNF-a gene was nearly similar to 
that in severe mastitic parenchymal tissues. It has been documented that animals with coliform 
mastitis secrete large amounts of TNF-a in their milk compared with healthy gland (20. 22). .A. 
basal level of expression of IL-la was also detected in non-challenged glands. The intensity 
of IL-la gene expression was similar to that of TNF-a, however, the number of cells 
expressing IL-la was substantially lower than those expressing TNF-a in non-challenged 
glands. Kremer et al postulated IL-1 as one of the major inflammatory reaction initiating 
mediators in coliform mastitis of mammary glands (16). Our finding of a low level of basal 
expression of IL-la and TNF-a suggest IL-la and TNF-a as the initiating inflammatory 
cytokines in bovine mammary tissues in response to E. coli. 
Another interesting cytokine was IL-6. At the gene level, we could barely detect IL-6 
mRNA in non-challenged glands. At the protein level, others have been unable to detect IL-6 
expression in normal cows (20). In the diseased gland, the level of IL-6 was significantly 
lower than the levels of IL-la and TNF-a expression both in terms of mRNA level per cell 
and the number of cells expressing the gene in mild mastitic parenchymal ti.ssues. In the 
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parenchymal tissue of severe mastitic glands, however, the intensity of IL-6 gene expression 
was increased 100% compare to mild mastitic glands while the increases of IL-la and TNF-a 
gene expression were only 30% and 20% respectively. This phenomenon was more prominent 
in the increased percentage of cells expressing cytokines. The proportion of cells expressing 
[L-6 gene in severe mastitic parenchymal tissues was 5 times greater than the proportion of 
cells expressing IL-6 gene in mild mastitic glands. In contrast, increases of ceils that expressed 
IL-la or TNF-a were 30% and 10% respectively. In severe coliform mastitis infection, milk 
of surviving animals contained significantly higher levels of IL-6 than milk from cows who 
died from the infection (20). IL-1 and TNF are potent inducers of IL-6 production and the role 
of IL-6 is more antiinflammatory rather than proinflammatory by antagonizing the effects of 
IL-1 and TNF (4, 18, 23). Therefore the role of IL-6 is different from proinflammatory 
cytokines even though IL-6 is classified as an acute phase cytokine. 
Expression of IL-ip and IFN-ygene was undetectable in non-challenged parenchymal 
tissues. However, expression intensity and the proportion of cells expressing the cytokine 
genes in both mild and severe mastitic glands were different for the values of IL-1 and IL-6. 
Cytokines can be detrimental to animal health if produced for too long of a period or in too 
high concentration (17. 19). Many reseai'chers have tried to relieve inflammation by treating 
infected glands with cytokine antagonists (25). hematopoietic cytokines (13. 14). or treating 
leukocytes with cytokines before infection (28. 29). Based upon mRNA expression. IL-la 
and TNF-a are the likely initiators of inflammation subsequent to bacterial infection of the 
mammary gland. 
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Figure 1. Rectal temperature oi Escherichia culi infused cows (n = 6 up to 6 h PC; n = 4 from 
6 h to 12 PC). 
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Figure 2. Number of colony forming unit (CFU) of Escherichia coli in milk of challenged 
glands (n = 6 up to 6 h PC; n = 4 from 6 h to 12 PC). At time 0. cattle were challenged in the 
right front quarter with 30 CFU of E. coli strain MacDonald 487 in 2 ml pyrogen free saline. 
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Figure 3. Average somatic cell counts of milk samples collected from Escherichia coli infected 
(gland A. n = 6 up to 6 h PC; n = 4 from 6 h to 12 PC) and non-infected (gland C, n = 6 up to 
6 h PC; n = 4 from 6 h to 12 PC) control mammary glands. 
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Figure 4. Tumor necrosis factor activity in whey samples recovered from Escherichia cuH 
infected (gland A, n = 6 up to 6 h PC; n = 4 from 6 h to 12 PC) and non-infected control 
(gland C, n = 6 up to 6 h PC; n = 4 from 6 h to 12 PC) mammary gland. The TNF activity 
was measured by bioassay with WEHI 164 cell line. The activity is an average of triplicates 
with standard error of mean. 
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Figure 5. Gene expression of IL-la specific mRNA is detected by in situ hybridization in 
parenchymal tissues of normal (left), mild coliform mastitis (center, 24 h PI with E. coli), and 
severe coliform mastitis (right) infected mammary gland of Holstein cows. Hybridized cells 
are stained with alkaline phosphatase and NBT/BCIP substrate (magnification = xlOO). 
Figure 6. Gene expression of IL-l|3 specific mRNA is detected by in situ hybridization in 
parenchymal tissues of normal (left), mild coliform mastitis (center. 24 h PI with E. coli), and 
severe coliform mastitis (right) infected mammary gland of Holstein cows. Hybridized cells 
are stained with alkaline phosphatase and NBT/BCIP substrate (magnification = xlOO). 
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Figure 7. Kinetics of cytokine gene expression in mammary parenctiymal tissues from 
experimentally Escherichia coli infected Holstein cows (at time 0 h, n = 6 and at 6, 12, and 24 
h post-infusion, n = 2 respectively). Level of gene expression was measured by the intensity 
of cytokine gene expression per cell. Subjective scoring of signal intensity was scaled 
according to the color reaction: 0 = no chromogen staining; 1 = pale blue; 2 = blue to purple; 
3 = dark purple. 
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Figure 8. Kinetics of cells that expressed cytokine gene in parenchymal tissues from 
experimentally Escherichia culi infected Holstein cows (at time 0 h. n = 6 and at 6, 12. and 
24 h post-infusion, n = 2 respectively). Positive cells are cells that hybridized with a given 
cytokine RNA probe thus stained with NBT/BCIP. Subjective scoring of positive cells was 
scaled according to the number of stained cells: 0 = no positive cells; 1 = 1-30% of cells 
positive; 2 = 30% to 70% positive cells; 3 = > 70% of cells positive. 
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Figure 9. Cytokine gene expression in mammary parenchymal tissues of Holstein cows that 
were infused with Escherichia coli experimentally (Mild mastitis. 24 h PI, n = 2) and infected 
with coliform mastitis (Severe mastitis, n = 7). Level of gene expression was measured by the 
intensity of cytokine gene expression per cell. Subjective scoring of signal intensity was scaled 
according to the color reaction: 0 = no chromogen staining; 1 = pale blue: 2 = blue to purple; 
3 = dark purple. 
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Figure 10. Relative amount of cells that expressed cytokine gene in parenchymal tissues from 
Holstein cows that were infused with Escherichia coli experimentally (Mild mastitis, 24 h PI. 
n = 2) and infected with coliform mastitis (Severe mastitis, n = 7). Positive cells are cells that 
hybridized with a given cytokine RNA probe thus stained with NBT/BCIP. Subjective scoring 
of positive cells was scaled according to the number of stained cells: 0 = no positive cells; 1 = 
1-30% of cells positive; 2 = 30% to 70% positive cells; 3 = > 70% of cells positive. 
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INFLUENCE OF p,-INTEGRIN ADHESION MOLECULE EXPRESSION AND 
PULMONARY INFECTION WITH PASTEURELLA HAEMOLYTICA ON 
CYTOKINE GENE EXPRESSION IN CATTLE 
A paper to be submitted Infection and Immunity 
Haa-Yung Lee, Marcus E. Kehrii. Jr., Kim A. Brogden and Mark R. Ackermann 
Abstract 
Beta, (P,)-integrins are leukocyte adliesion molecules composed of alpha (GDI la. b. c or 
d) and beta (CD18) subunit heterodimers. Genetic GD18 deficiency (GDIS') results in 
impaired neutrophil egress into tissues that varies between conducting airways and alveoli of 
the lung. In this study, we investigated whether or not GDIS deficiency in cattle affects acute 
phase cytokine (APG) expression in pulmonary tissue after respiratory infection with 
Pcisteurellci haemolytica. To investigate this, cattle were infected with P. haeniolytica via 
fiberoptic deposition of organisms into the posterior part of the right cranial lung lobe. 
Animals were euthanized at 2 or 4 hours post-inoculation (PI) and tissues were collected to 
assess acute phase cytokine gene expression using anti-sense RNA probes specific for bovine 
interleukin-la (IL-la), IL-ip, IL-6. interferon-Y(IFN-y), and tumor necrosis factor-a 
(TNF-a) along with beta-actin (P-Act), a house keeping gene. In the GDIS" cattle, the 
expression of IFN-y and TNF-a genes were not increased in P. hciemulytica inoculated lungs 
compared to the pyrogen free saline (PFS) inoculated control lungs. In the PFS inoculated 
lungs, there was a tendency that higher percentage of cells and higher level of gene expression 
were observed in the lungs of GDIS" cattle than in the lungs of GDIS'' cattle. Expression of 
APG was induced at 2 h PI in P. haemolytica infected cattle and increased at 4 h PI. At 2 h 
PI, levels of gene expression between GDIS" and GDIS" cattle were not significantly different. 
At 4 h PI, the lungs of GDIS'' cattle expressed stronger signals of IL-la and IFN-y than that of 
the GDIS" cattle. When compared to PFS inoculated lung tissues, the increase of IL-1 a. IL-6. 
IFT^-y, and TNF-a gene expression in the lung of GDI8^ cattle at 4 h PI with P. haemolytica 
was greater than that of GDIS' cattle in terms of either intensity of gene expression or 
percentage of APG gene expression positive cells. The rate of neutrophil infiltration into the 
lungs of the GDIS" cattle at 2 h PI with P. haemolytica was significantly higher than that of 
GDIS^ cattle but at 4 h PI. there was no difference between the two groups. These data 
suggest that P^-integrins may contribute to the induction of some APG gene expression as a 
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suggest that P^-integrins may contribute to the induction of some APC gene expression as a 
consequence of P. haemolytica infection. 
Introduction 
Biotype A serotype 1 (Al) Pcisteiirella haemolytica is the primary bacterium responsible for 
shipping fever or bovine pneumonic pasteurellosis (33). This disease is characterized by acute 
lobar tlbrinonecrotizing pneumonia (33, 47, 48). Several virulence factors of P. haemolytica 
have been identified (15). Lipopolysaccharide (LPS) and leukoto.xin are the most well known 
stimulators of inflammation in bovine pneumonic pasteurellosis (11. 13, 15, 41, 44, 45,47, 
48). These virulence factors stimulate a variety of respiratory tract cells such as alveolar and 
intravascular macrophages, mast cells, and endothelial cells, and these cells express and 
produce inflammatory mediators. The inflammatory mediators secreted by respiratoiy tract 
cells are acute phase cytokines (APCs) such as interleukin-1 (IL-I), IL-6, tumor necrosis 
factor-a (TNF-a), complement components, hydrolytic enzymes, and chemokines (20, 27, 
32, 37, 39, 40, 46). Once secreted, these inflammatory mediators trigger an intlammatory 
cascade. .Neutrophils are known to be the primary infiltrating inflammatory cells involved in 
clearing infections in the lungs, however, prolonged activation of neutrophils may induce 
severe tissue damage by the production of oxygen-derived free radicals and enzymes such as 
elastase (9, 10, 17, 26, 43). Furthermore, these intlammatory mediators induce expression of 
adhesion molecules on leukocytes and endothelial cells that facilitate the infiltration of 
additional leukocytes into inflamed tissues (6, 9, 10, 26, 43). 
Bovine leukocyte adhesion deficiency (BLAD) is an autosomal recessive genetic disease 
resulting from one amino acid substitution (D128G) in the P subunit (CD 18) of the p,-integrin 
(CDl I/CD18) superfamily (LFA-1. Mac-1, pl50, 95) (23-25, 31, 34. 38). This p,-integrin 
mediates tight adhesion of leukocytes onto endothelial membrane of inflamed tissue (3). 
Leukocytes from BLAD affected animals express no functional CD 18 (3). The affected 
animals (BLAD or CD18') suffer recurrent bacterial, viral or fungal infections (5, 23-25. 29, 
30). Cattle with CD 18" often die because of respiratory or enteric infections despite antibiotic 
therapy (4). Another prominent characteristic of BLAD is progressive neutrophilia due to 
impaired transmigration of neutrophils across vascular endothelium into sites of infection (2, 4, 
19). In pneumonic lungs of CD 18" cattle, however, remarkable levels of neutrophil infiltration 
were observed in the alveolar lumina (2, 4). Binding of p, integrin with LPS or the counter 
receptor, intercellular adhesion molecule (ICAM), activates resting leukocytes (8, 19, 22, 28). 
In this study, we compared APC gene expression in lungs of CD 18" and CD 18" cattle at 2 and 
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4 hours after experimental inoculation with P. haemolytica. In situ hybridization was used to 
measure APC gene expression. 
Materials and Methods 
Animals and Pasteurella haemolytica inoculation 
Twelve Holstein cattle were used for this experiment. Half of them were confirmed CD 18" 
homozygous and the other half were age matched normal GDIS'" cattle (23-25, 34, 38). Both 
GDIS" (BLAD) and GDIS"' (Normal) cattle were inoculated with 8 ml of 1x10' colony-
forming units (GFU)/ml P. haemolytica in pyrogen-free saline (PFS) followed by 10 ml of 
sterile PFS by fiberoptic bronchoscopy into the right cranial lung lobe as described previously 
(12). The left lobe of the lung was inoculated with 18 ml of sterile PFS and served as saline 
treated conu-ol. .Animals were euthanized at 2 and 4 hours post-inoculation (PI) with P. 
haemolytica. Lung tissues were collected at necropsy and fi.xed in neutral buffered 10% zinc 
formalin for histological preparation. 
Probe synttiesis for in situ hybridization 
Bovine sequence specific RNA probes for five different APCs. interleukin-la (IL-la), IL-ip, 
IL-6, interferon-y (IFN-y), tumor necrosis factor-a (TNF-a) and a hou-se-keeping gene, beta-
actin (p-Act) were synthesized. Briefly, cDNA was reverse transcribed from bovine leukocyte 
total RNA using random hexameric primers and subjected to PGR amplification using probe 
specific primer pairs (Table I). The amplified DNA fragments of 156, 180, 201, 250. 119, 
and 80 base pairs for IL-la, IL-I(3, IL-6, IFN-y, TNF-a and p-.Act, respectively, were cloned 
into a pGEM4 vector (Promega, Madison, VVI), transformed into E. coli strain JiMIOQ, and 
their sequences were confirmed by dideoxy sequencing. For riboprobe synthesis, plasmid 
DNA was isolated and linearized with either EcoRl or HincUll restriction endonucleases. for 
antisense or sense strand probe, respectively. 
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Table I. Sequence of oligomers used for polymerase chain reaction amplification of bovine 
cytokine specific cDNA fragments used for synthesis of riboprobes. 
IL- la forward primer 5'- GCGAATTCACAGCAGTTGGAATAAGCCGTG -3' 
IL- la backward primer 5'- CCAAGCTTGCACAGAGTTGGACATGACTGAAG -3' 
IL-1P forward primer 5'- GCGAATTCAAGGCTCTCCACCTCCTCTC -3' 
IL-1P backward primer 5'- CCAAGCTTGTCTACTTCCTCCAGATGCA -3' 
IL-6 forward primer 5'- GCGAATTCTGGGTTCAATCAGGCGATTTG -3' 
IL-6 backward primer 5'- CCAAGCTTAGGTCAGTGTTTGTGGCTGGAGTG -3' 
IFN-y forward primer 5'- GCGAATTCTTACTGCTCTGTGGGCTTTTGG -3' 
IFN-y backward primer 5 -CCAAGCriTGCTCCriTGAAl GACCIGGITAl C-3' 
TNF-a forward primer 5'- GCGAATTCAAGCC(rrGGTACGAACCCAT<rrAC -3' 
TNF-a backward primer 5'- CCAAGCITIAGACCIGCCCAGACTCAGCATAG -3' 
P-Act forward primer 5'- GCGAATTCCTGTCCACCTTCCAGCAGATGT -3' 
p-Act backward primer 5'- CCAAGCrrriCGAAAACGCCACCIG ITACC -3' 
The linear plasmid DNA was transcribed in vitro using either T7 or SP6 RNA polymerase 
with ATP, CTP, GTP and digoxigenin labeled LTP (Boehringer Mannheim, Indianapolis, IN) 
as a labeling agent for antisense and sense strand probe respectively. The antisense strand 
probe was used for detection of gene expression because it hybridizes with mRNA by forming 
a complimentary double strand. The sense strand probe was used as a negative control to 
assess non-specific binding. 
In situ hybridization 
Paraffin-embedded tissue sections were deparaffinized and treated with 10 }ig/ml proteinase 
K (Boehringer Mannheim, Indianapolis. IN) for 30 minutes at 37° C. After washing slides 
with diethyl pyrocturbonate (DEPC, Sigma. St. Louis, .MO) treated phosphate buffered saline, 
slides were dried. Fifty |il of RNA probe (0.5 mg of RNA/ml) in hybridization solution (50% 
formamide. 25% DEPC-H-,0, 3 X sodium chloride/sodium citrate. 1 X Denhardt's solution. 
0.2 mg/ml yeast tRNA, 50 rruVI sodium phosphate, pH 7.4 and 10% dextran sulfate) was 
applied onto a sample slide and covered with a coverslip. Slides were heated at 90° C for 10 
minutes and were hybridized 16 hours in a humidified chamber at 60° C. To remove unbound 
probe, slides were incubated for 30 minutes at 37° C with RNase A (20 mg/ml. Boehringer 
-Mannheim. Indianapolis, IN), washed sequentially in 2 X SSC, IX SSC for 5 minutes each 
and 0.5 X SSC for 1 hour at 60° C. and finally with 0.5 X SSC for 5 minutes at room 
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temperature. Slides were then incubated with sheep anti-digoxigenin antibody labeled with 
alkaline phosphatase and developed in 5-bromo-4-chloro-3-indolylphosphate/nitro-blue 
tetrazolium (NBT/BCIP, Boehringer Mannheim, Indianapolis. IN) solution in the dark for 18 
hours. After chromogen development, slides were counterstained with nuclear fast red for 3 
minutes and coverslips were mounted with aqueous mounting media (Accurate Chemical & 
Scientific Corp, Westbury, NY) (7). 
Macrophage staining 
Monoclonal antibody EBMl I (anti-CD68, DAKO, Carpenteria. CA) was used for 
detection of macrophages in lung tissues (I). Brietly, sections of lung tissues were 
deparaffmized and treated with 0.25% bacterial protease (Type XIV. Sigma. St. Louis. .VIO) in 
Tris buffer (pH 7.6) for 30 minutes at 37° C. The primary antibody, monoclonal mouse anti-
CD68. was diluted 1:25 and applied and incubated overnight at 4° C. Peroxidase-labeled goat 
anti-mouse IgG was used for secondary antibody with 3'3-diaminobenzidine substrate 
(Vectastain ABC Kit, Vector Laboratories, Burlingame, CA). Slides were counterstained with 
hematoxylin. 
Neutrophil staining 
For the neutrophil staining, lead thiocyanate (Pb (II) SCN, Aldrich. Milwaukee. \VI) was 
used for antigen retrieval in this experiment (manuscript in preparation). Deparaffmized tissues 
were treated in boiling Pb (II) SCN (1%) for 1.5 minutes, then remained in the same solution 
additional 10 minutes with heat turned off (beaker still on heating block). Slides were allowed 
to cool for 15 minutes at room temperature in the saturated Pb (II) SCN solution under a hood. 
Endogenous peroxidase blocking was performed for 20 minutes at room temperature. The 
sections were treated with 10% normal goat serum for 15 minutes and labeled with 1:150 
dilution of secondary antibody [anti-mouse IgG (Fab-specific) biotin conjugated. Sigma. St. 
Louis, MO] for 1 hour at room temperature. The sections were incubated with streptavidin-
horse radish peroxidase (Kirkegaard & Perry Laboratories. Gaithersburg, MD) for 30 minutes 
and subjected to a color reaction with diaminobenzidine (DAB. Kirkegaard & Perry 
Laboratories, Gaithersburg, .MD) for 15 minutes. After 15 minutes incubation, the sections 
were counterstained with hematoxylin for I minutes and coverslipped. 
Data analysis 
Two scoring system were applied to 5 independent fields on each slide. The first 
assessment was to evaluate the level of gene expression on a per cell basis. Subjective scoring 
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of signal intensity was scaled according to the color reaction: 0 = no chromogen staining; 1 = 
pale blue; 2 = blue to purple; 3 = dark purple. Another criterion for the scoring system was the 
percentage of positive cells identified in the first evaluation. Subjective scoring of positive cells 
was as follows: 0 = no positive cells; 1 = 1-30% of cells positive; 2 = 30% to 70% positive 
cells; 3 = > 70% of cells positive. The mean of each slide was calculated from 5 independent 
observations in a given sample. The mean of a given group was an average of the individual 
tissue mean with standard error of mean. 
An ANOVA test was used to evaluate the effects of CD 18 and P. haemolyiicu inoculation 
for the expression of the APC genes. The same letter for a given cytokine measurement means 
there is no significant difference between groups for the cytokine e.xpression. The different 
letter for a cytokine result means the averages between comparing groups are statistically 
significantly different. 
Results 
Various levels of cytokine gene expression were detected by cytokine specific RNA probes 
(Figure 1). Inoculation of P. hciemolyticci induced APC gene expression and increased 
numbers of APC gene expressing cells in lungs of both CD 18' and CD 18' cattle at both 2 and 
4 h PI when compared to PFS inoculated lungs (Figures 2-5). Augmentation of .A.PC gene 
expression at 2 h PI with P. hciemolyticci was not significantly different between CD 18" and 
CD 18" cattle and almost the same between the two groups (Figure 2). Increased number of 
cells with APC expression was also similar in the lungs of CD 18" and CD 18" cattle at 2 h PI 
with P. hciemolytica (Figure 3). Some cytokines increased progressively in CD 18" cattle 
treated with P. hciemolyticci. That is, significantly {P<0.05) increased gene expression of 
IL-la. IL-6, and IFN-ywas present at 4 h PI in P. hciemolyticci inoculated lungs of CD 18" 
cattle when compared to the gene expression in the lungs of P. hciemolyticci inoculated CD 18* 
cattle at 2 h PI (Figure 2 and 4). .Acute phase cytokine expression by cells in lungs of CD 18" 
cattle at 4 h PI was increased significantly (P<0.05) for all cytokines that we measured in 
P. hciemolyticci inoculated lung in comparison to PFS inoculated lungs (Figure 4). In CD 18' 
animals, expression levels of IL-la and IL-ip were increa.sed significantly (P<0.05) but IL-6, 
IFN-y and TNF-a gene were not significantly increased in P. hciemolyticci inoculated lung at 4 
h PI when compared to PFS inoculated lungs (Figure 4). When APC gene expression levels 
of P. hciemolyticci inoculated lungs of both CD 18" and CD 18" cattle were compared with that of 
PFS inoculated lungs, the increase of APC gene expression in the lungs of CD 18" cattle was 
significantly (P<0.05) higher for all cytokines, except for IL-ip. than that of the CD 18" cattle 
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(.Figure 4). Also at 4 h PI, P. haemolytica inoculated lungs of CD 18' cattle expressed 
significantly (P<0.05) higher levels of IL-la and IFN-y genes than P. haemolytica inoculated 
lungs of CD18' cattle (Figure 4). The findings of increased AFC gene expression in CDIS"" 
cattle at 4 h PI in response to P. haemolytica inoculation when compared to CD 18" cattle 
indicates that CD 18"^ cattle can express higher level of some cytokines than CD 18" cattle. 
For the number of APC gene expressing ceils, the lungs of CD 18" cattle had significantly 
(P<0.05) more cells that expressed lL-6, IR^f-y, and TNF-a at 4 h PI with P. haemolytica 
than CD 18" cattle (Figure 5). In the PFS inoculated lungs. CD 18" cattle had a tendency (that 
was not statistically significant) to express higher levels of APC genes and had more cells 
expressing APC genes than CD IS'' cattle, especially in 4 h PI groups (Figure 4 and 5). 
Increased number of neutrophils and macrophages, in P. haemolytica inoculated lungs was 
observed (Figure 6 and Table 2). Neutrophils were more prominent cells than macrophages in 
P. haemolytica inoculated bovine lungs (Table 2). The neutrophil percentage in CD 18" animals 
was significantly higher than in CD 18" animals at 2 h PI (P<0.05 ) but at 4 h PI. there was no 
significant difference of neutrophil percentage between two animal groups (Table 2). 
Table 2. Percentage of labeled neutrophils and macrophages in the lung of CD 18" and CD 18" 
cattle after 2 or 4 hours post-inoculation with pyrogen free saline (PFS) or Pasteiirellu 
haemolytica {P. hae) 
2 h PI 4 h PI 
-Neutrophils (%)* Macrophages (%) Neutrophils (%) Macrophages (%) 
CD 18"-PFS 13.3 ± 4.1 13.3 ± 4.1 13.3 ± 4.1 13.3 ± 5.4 
CD 18"-P. hae 23.3 ± 4.1 20.0 ± 7.1 43.3 ± 4.1 23.3 ±4.1 
CD 18"-PFS 16.7 ± 2.0 16.7 ± 4.1 13.3 ± 4.1 21.7 ± 5.4 
CD 18"-P. hae 36.7 ±4.1 16.7 ± 8.2 50.0 ± 12.2 30.0 ± 7.1 
* Percentages were calculated by diving the number of specifically stained cells from all cells 
that counted in 5 randomly chosen sites 
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Discussion 
Basal APC gene expression in PFS inoculated lung tissues of CD 18" cattle had a tendency 
of higher expression than that seen in CD 18" cattle under "non-diseased" condition. This 
phenomenon may be the result of chronic activation of the CD 18" animal's immune system due 
to recurrent and/or chronic infection (23-25. 29, 30). Kehrli et al. reported selected functional 
abnormalities of neutrophils in CD 18" cattle (23, 24, 30). They obser\'ed diminished activities 
of phagocytosis, ingestion and associated reactive oxygen generation, myeloperoxidase-
dependent iodination, and extracellular release of elastase by neutrophils from CD 18" animals 
(23, 24, 30). All these dysfunctions of CD 18" neutrophils are related to the lack of functional 
activities of complement receptors (CR3 and CR4) that are part of (3,-integrin functions. 
The function of integrin is not restricted to mediating cell to cell adherence and migration of 
immune cells but also involved in signal transduction (17, 18. 35. 36. 42). Expression of 
APC genes went up in tissues of both CD 18'' and CD 18" cattle following inoculation with 
P. haemolyticci. At 2 h PI. the augments of APC gene expression and of percentages of APC 
gene expressing cells with P. haemulyiica inoculation were almost the same between CD 18'' 
and CD 18" cattle. At 4 h PI, however, the lung tissue of CD 18" cattle expressed higher levels 
of IL-la and IFN-y genes than the lung tissue of the CD 18" cattle. The increa.se of IL-la, 
IL-6, IFN-y, and TNF-a gene expression in the lung of CD 18" cattle was greater than that of 
CD 18" cattle in terms of either intensity of gene expression or percentage of APC gene 
expression positive cells. Moreover in the CD 18" cattle, the expression of the IFN-yand 
TNF-a gene were not increased at all in the P. haemolyticci inoculated lungs compared to the 
PFS inoculated lungs at 4 h PI. The main difference between the two groups of calves was 
suspected the ability to sustain gene expression. The molecular mechanism of the signal 
transduction of p,-integrins is not clearly understood (36). It is clear, however, that these 
proteins play an important role in immune responses by coordinating various immunological 
and mechanical stimulation via cytoskeletal proteins that result in a better immune response by 
the host (35, 36). Flaherty et al. observed that P^-integrin mediates signal transduction in 
response to LPS in a P,-integrin gene transfected Chinese hamster ovar\' fibroblast cell line 
(18). These data suggest p,-integrins contribute in vivo to induce APC gene expression, 
especially IFN-yand TNF-a gene expression, as a consequence off. haeniolyiica infection. 
Therefore CD 18" cattle could not respond properly to the P. luieinolyrica infection. 
Ackermann et al. reported that the number of resident immune cells in the alveolar septum 
of CD 18" animals is substantially greater than in CD 18" animals (2). They proposed three 
possible mechanisms for neutrophil infiltration into the lung alveoli of CD 18" cattle: migration 
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through porelike fenestrae, CD18-independent adherence, and septal degradative processes (2). 
At 2 h PI. the percentages of neuU^ophils in the lungs of P. hciemolytica inoculated CD 18" cattle 
were significantly higher than in GDIS'' cattle (P<0.05) but at 4 h PI there was no difference 
between two groups. Compare to CD18"' cattle, the increment of neutrophil percentages in the 
lungs of P. hciemolytica inoculated CD 18" cattle was higher at 2 h PI. Neutrophils have been 
shown to be the primary inflammatory cells that migrate to infection site (17). The higher 
percentage and faster infiltration of immune cells seen in the CD 18" animals at 2 h PI with 
P. hciemolytica may be a compensatory mechanism to cope with the immune malfunction of 
the host. One of the characteristics of CD 18" animals is elevated leukocyte counts in their blood 
due to a striking neutrophilia (19. 23. 25). The leukocytosis may contribute to the high 
number of leukocytes in the lung tissues of CD 18" animals after P. hciemolytica inoculation by 
simply increasing the chance of random migration. In contrast to neutrophils, the percentages 
of macrophages in the lungs after challenge with P. hciemolytica were not significantly 
different at both time points. Doerschuk et al. also observed CD18-independent migration of 
neutrophils into the lungs of rabbits challenged with Streptococcus pneumoniae (14. 16). 
Recently, it was demonstrated that neutrophils may transmigrate endothelium by activation of 
C5a and adhesion ligands such as E-selectin. independent from CD 18 (2. 21). Furthermore, 
neutrophils within the alveolar septum may release many tissue damaging materials such as 
proteases, fatty acid metabolites, and radical oxygen metabolites, thus facilitating leukocytes 
infiltration into parenchymal tissue regardless of CD 18 e.xpression (2). 
This study suggest that even though leukocytes of the CD 18" animal can transmigrate into 
the lung of the infected animal, the cells are unable to clear invading pathogens efficiently 
because of the impairment of selective immune functions. Therefore the CD 18" animals have 
more episodes of infections and more persisting infections. 
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Figure 1. Photomicrographs of bovine lung tissues in which IL-la or IFN-y specific mRNA is 
detected by in situ hybridization. Hybridized cells are stained with alkaline phosphatase and 
NBT/BCIP substrate (magnification = x 100). I = Normal (.CD 18") cattle inoculated with PFS 
and detected for IFN-7, 2 = BLAD (CD 18") cattle inoculated with P. haemolytica and detected 
for IFN-y; 3 = Normal (CD 18") cattle inoculated with PFS and detected for IL-la; 4 = BLAD 
(CD 18") cattle inoculated with P. haemolytica and detected for IL-la. 
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Figure 2. Differences of acute phase cytokine gene expression in pulmonary tissues from 
Pcisteiirellci hciemolytica infected {P. hae) and non-infected (PFS) lobes in CD IS"' and CD 18" 
cattle 2 hours post-inoculation. 
* Level of cytokine gene expression means the intensity of staining per cell. Subjective scoring 
was applied according to the color reaction: 0 = no signal; 1 = low expression; 2 = moderate 
expression; 3 = high expression. The scores are presented by average of the individual tissue 
within group with standard error of mean (,n = 3). 
The same letter (a, b, c, or d) for a given cytokine measurement means there is no significant 
difference between groups for the cytokine expression. The different letter for a cytokine result 
means the averages between comparing groups are statistically significantly different (P<0.05). 
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Figure 3. Amount of Cells that expressed acute phase cytokine gene in pulmonary tissues from 
Pasteurella haemolvtica infected (P. hae) and non-infected (PFS) lobes in CD IS'' and CD 18" 
cattle 2 hours post-inoculation. 
* Cytokine expression positive cells are estimates of the percentage of cells that hybridized 
with a given cytokine RNA probe. Most stained cells were macrophages and neutrophils. 
Subjective scoring system was applied for the estimation of positive cells: 0 = no positive cells; 
1 = < 30% of positive cells among total cells; 2 = 30% -70% positive cells among total cells; 
3 = > 70% positive cells among total cells. The scores are presented by average of the 
individual tissue within group with standard error of the mean (n = 3). 
The same letter (a, b, c, or d) for a given cytokine measurement means there is no significant 
difference between groups for the cell numbers that express the given cytokine mRNA. The 
different letter for a cytokine result means the averages cell numbers between comparing 
groups are statistically significantly different (P<0.05). 
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Figure 4. Differences of acute phase cytokine gene expression in pulmonary tissues from 
Pasreurella liaemolytica infected (P. hae) and non-infected (PFS) lobes in CD 18' and CD 18 
cattle 4 hours post-inoculation. 
* Legend is same with Figure 2. 
67 
•5$* 
<u 
o 
>> 
CO 
CU 
5, X 
<u 
y: 
13 
U 
a a a a 
N CD18+-PFS • CD18--PFS 
Q CD18+-P./ZFLE H CDIS- -P .hae  
IL-LA IL-IP IL-6 INF-Y TNF-A P-Act 
Figure 5. Amount of Cells that expressed acute phase cytokine gene in pulmonary tissues from 
Pasteurella haemolytica infected (P. hue) and non-infected (PFS) lobes in CD 18* and CD 18" 
cattle 4 hours post-inoculation 
* Legend is same with Figure 3. 
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Figure 6. Photomicrographs of bovine lung tissue stained with either monoclonal mouse anti-
CD68 for macrophages or goat anti-mouse IgG (Fab specific) for neutrophils (magnification = 
X 250). 1 = BLAD (CD18 ) cattle inoculated with PFS and detected for neutrophils; 2 = BLAD 
(GDIS ) cattle inoculated with P. hciemolytica and detected for neutrophils: 3 = BLAD (GDIS') 
cattle inoculated with PFS and detected for macrophages; 4 = BLAD (GDIS ) cattle inoculated 
with P. hciemolytica and detected for macrophages. 
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CYTOKINE GENE EXPRESSION IN ILEAL TISSUES OF CATTLE 
INFECTED WITH MYCOBACTERIUM AVIUM SUBSP. 
PARA TUBERCULOSIS 
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Abstract 
Cytokine gene expression in ileal tissues of Mycobacterium avium subsp. paratuberculosis 
infected cattle was evaluated. The number of resident macrophages in the ileum of 
paratuberculosis positive animals were 3 times more than that of paratuberculosis negative 
animals. In contrast to this, ileal tissues from paratuberculosis negative animals contained 1.5 
times more neutrophils than in the ileal tissues from paratuberculosis positive animals. 
Paratuberculosis is a chronic disease and malfunction of macrophages may be related to the 
pathogenesis of disease. Among cytokines we studied, interleukin-la (IL-la), IL-lp. IL-6. 
and interferon-Y(IFN-yj were expressed significantly more in paratuberculosis positive animals 
than in paratuberculosis negative animals (P<0.05). The expression of tumor necrosis factor-a 
(TNF-a), however, was not different between the two groups of cattle. Based on the 
observations, it is postulated that the constitutively high expression of IL-1 induces IL-6 
secretion. The high level of IL-6 may in turn suppress cell-mediated immune responses 
exerted by IFN-yand TNF-a. The results of these effects on cytokine production and immune 
regulation is the chronic infection of cattle with paratuberculosis. 
Introduction 
Paratuberculosis (Johne's disease) is a chronic enteritis in ruminants caused by the 
facultative intracellular pathogen, Mycobacterium avium subsp. paratuberculosis (2, 10. 35). 
Transmission of the disease is primarily via the fecal-oral route to young calves from clinically 
infected dams while adult animals appear to be resistant to infection (10, 35, 36). The 
characteristic signs of clinical infections are wasting, recurrent diarrhea, rough hair coat, or 
death (10, 37). The estimated economic loss in the U.S. from paratuberculosis in cattle herds 
is more than S1.5 billion/year (35). 
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Mycobacteria are rod-shaped, acid fast, non-motile facultative intracellular bacilli with a 
characteristically high content of lipid in their cell walls. The mechanism(s) of pathogenesis 
associated with mycobacterial diseases is not clearly elucidated. However, many investigators 
have implicated the lipid components such as cord factor (trehalose 6-6' dimycolate). mycolic 
acid, glycosyl phenolphthiocerol dimycocerosate, phthiocerol dimycocerosate, phthiocerosate, 
sulpolipid. hydroxy-phthioceranate, glycopeptidolipids, and arabinogalactan of the 
mycobacterial cell wall as important factors in the pathogenesis of mycobacterial diseases (3, 4. 
10. 25, 27, 33, 41). Moreover, a "capsule-like structure" has been studied and it is postulated 
that this structure renders to the bacteria multiple drug resistance, pathogenicity, virulence, and 
molecular interactions with host cells (6, 21, 26, 30, 45). 
The primary host defense mechanism against mycobacteria is phagocytosis of the invading 
acid-fast bacilli. This nonspecific natural defense is mediated by phagocytes, mainly 
macrophages. However, pathogenic acid-fast bacilli are relatively resistant to the degradative 
mechanisms of macrophages. In fact, virulent mycobacteria may survive and multiply within 
macrophages rather than be killed (25). It is suggested that mycobacteria can survive inside of 
the macrophage by disarming several defense mechanisms of macrophages such as elevated 
synthesis of stress proteins, oxygen radicals, disruption of phagosomal membranes as well as 
inhibit macrophage priming and activation (25. 32). Pathogenic mycobacteria establish chronic 
infections and form granulomas. The macrophages and lymphocytes within granuloma secrete 
many cellular necrotic factors including acute phase cytokines (APCs) which may subsequently 
lead to tissue necrosis and e.xtensive fibrosis (21). Acute phase cytokines, such as 
interleukin-1 (IL-1), IL-6, and tumor necrosis factor (TNF). are imponant mediators/regulators 
of host defense and facilitate both cell-mediated and humoral immunity. However, in 
mycobacterial infections including paratuberculosis, the cytokines mediate formation of 
granuloma and chronic inflammatory states (3. 4). 
Studies performed to evaluate effects of incubation of paratuberculosis-negative bovine 
whole blood or murine macrophage cell lines with either M. avium siihsp. parciniberculusis 
lipoarabinomannan (LAM), muramyl dipeptide (MDP) or live bacilli show increased 
expression of IL-1 (3. IL-6 and TNF-a genes (3, 4). Following stimulation with either E. coli 
LPS or M. avium subsp. paratuberculosis LAM. similar expression of lL-6 and TNF-a 
specific mRNA was demonstrated in cultures of whole blood regardless of the fact that the cells 
were isolated from noninfected or infected cattle (2). The role of cytokines in the regulation of 
mycobacterial infection is very complicated and not clearly understood. In the present study, 
we utilized in situ hybridization to detect effects of paratuberculosis on expression of various 
APC genes in bovine ileal tissues. 
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Materials and Methods 
Tissue preparation 
Fifteen Holstein cattle were used for this experiment. Seven were paratuberculosis positive 
as characterized by repeated positive fecal cultures over a 3-5 year period. The remainder were 
paratuberculosis free cattle. All the paratuberculosis positive animals were clinically infected 
according to fecal shedding (>100 CFU/g feces) of M. aviiini siibsp. paratuberculosis . The 
animals were euthanized and the ileal samples of all cattle were collected at necropsy and tlxed 
in neutral buffered 10% zinc formalin for histologic preparation. 
Probe synthesis for in situ hybridization 
Bovine sequence specific RNA probes for tlve different APCs, IL-la, IL-ip, IL-6, 
interferon-y (IFN-y), TNF-a and a house-keeping gene, beta-actin (P-Act) were synthesized. 
Briefly, cDNA was reverse transcribed from bovine leukocyte total RNA using random 
hexameric primers and subjected to PCR amplification using probe specific primer pairs 
(Table 1). The amplified DNA fragments of 156, 180, 201, 250. 119. and 80 base pairs for 
IL-la, IL-ip. IL-6, IFN-y, TNF-a and P-Act respectively, were cloned into a pGEM4 vector 
(Promega, Madison, WI), transformed into E. coli strain JM109. and their sequences were 
confirmed by dideo.xy sequencing. 
Table 1. Sequence of oligomers used for polymerase chain reaction amplification of bovine 
cytokine specific cDNA fragments used for synthesis of riboprobes. 
IL-1 a forward primer 5'- GCGAATTCACAGCAGTTGGAATAAGCCGTG -3' 
IL-la backward primer 5'- CCAAGCTTGCACAGAGTTGGACATGACTGAAG -3' 
IL-1P forward primer 5'- GCGAATTCAAGGCTCTCCACCTCCTCTC -3' 
IL-ip backward primer 5'- CCAAGCTTGTCTACTTCCTCCAGATGCA -3' 
IL-6 forward primer 5'- GCGAATTCTGGGTTCA.ATCAGGCGATTTG -3' 
IL-6 backward primer 5'- CCAAGCTTAGGTCAGTGTTTGTGGCTGGAGTG -3' 
IFN-y forward primer 5"- GCGAATTCTTACTGCTCTGTGGGCTTTTGG -3' 
IFT^f-y backward primer 5'- CCAAGCTTTGClCCrriGAAlGACClGGri Arc -3' 
TNF-a forward primer 5'- GCGAATTCAAGCCCTGGTACGAACCCATCTAC -3' 
TNF-a backward primer 5'- CCAAGCTTTAGACCTGCCCAGACTCAGCATAG -3' 
P-Act forward primer 5'- GCGAATTCCTGTCCACCTTCCAGCAGATGT -3' 
P-Act backward primer 5'- CCAAGClTlTCGAAAACGCCACCl Gri ACC -3' 
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For riboprobe synthesis, plasmid DNA was isolated and linearized with either EcoR 1 or 
HinJlll restriction endonucleases, for antisense or sense strand probe, respectively. The linear 
plasmid DNA was transcribed in vitro using either T7 or SP6 RNA polymerase with ATP, 
CTP, OTP and digoxigenin labeled UTP (Boehringer Mannheim, Indianapolis, IN) as a 
labeling agent for antisense and sense strand probe respectively. The antisense strand probe 
was used for detection of gene expression because it hybridizes with mRNA by forming a 
complimentary double strand. The sense strand probe was used as a negative control to assess 
non-specific binding. 
In situ hybridization 
Paraffin-embedded tissue sections were deparaffinized and treated with 10 ug/ml proteinase 
K (Boehringer Mannheim, Indianapolis, IN) for 30 minutes at 37"^ C. After wash slides with 
diethyl pyrocarbonate (DEPC, Sigma, St. Louis, MO) treated phosphate buffered saline, dried 
slides. Fifty jj.1 of RNA probe (0.5 mg of RNA/ml) in hybridization solution (50% formamide. 
25% DEPC-H,0, 3 X sodium chloride/sodium citrate (SSC), 1 .X Denhardt's solution, 0.2 
mg/ml yeast tRNA, 50 mM sodium phosphate. pH 7.4 and 10% dextran sulfate) was applied 
onto a sample slide and covered with a coverslip. Slides were heated at 90° C for 10 minutes 
and were hybridized for 16 hours in a humidified chamber at 60° C. To remove unbound 
probe, slides were incubated for 30 minutes at 37° C with RNa.se A (20 mg/ml. Boehringer 
Mannheim, Indianapolis, IN), washed sequentially in 2 X SSC. IX SSC for 5 minutes each 
and 0.5 X SSC for 1 hour at 60° C, and finally with 0.5 X SSC for 5 minutes at room 
temperature. Slides were then incubated with sheep anti-digoxigenin antibody labeled with 
alkaline phosphatase and developed in 5-bromo-4-chloro-3-indolylphosphate/nitro-blue 
tetrazolium (NBT/BCIP, Boehringer Mannheim, Indianapolis. IN) solution in the dark for 18 
hours. After chromogen development, slides were counter-stained with nuclear fast red for 3 
minutes and coverslips were mounted with aqueous mounting media (.Accurate Chemical & 
Scientific Corp, Westbury, NY) (5) 
Macrophage staining 
Monoclonal antibody EBMl 1 (anti-CD68, DAKO, Carpenteria. C.A) was used for 
detection of macrophages in ileal tissues (1). Briefly, sections of ileal tissues were 
deparaffinized and treated with 0.25% bacterial protease (Type XIV, Sigma, St. Louis, MO) in 
Tris buffer (pH 7.6) for 30 minutes at 37° C. The primary antibody, monoclonal mouse anti-
CD68, was diluted 1:25 and applied and incubated overnight at 4° C. Peroxidase-labeled goat 
73 
anti-mouse IgG was used for secondary antibody with 3'3-diaminobenzidine substrate 
(Vectastain ABC Kit, Vector Laboratories, Burlingame, CA). Shandon's hematoxylin was 
used for counterstaining. 
Neutrophil staining 
For the neutrophil staining, lead thiocyanate (Pb (II) SCN, Aldrich. Milwaukee, WI) was 
used for antigen retrieval in this experiment (manuscript in preparation). Deparaffmized tissues 
were treated in boiling Pb (II) SCN (1%) for 1.5 minutes, then remained in the same solution 
additional 10 minutes with heat turned off (beaker still on heating block). Slides were allowed 
to cool for 15 minutes at room temperature in the saturated Pb (II) SCN solution under a hood. 
Endogenous peroxidase blocking was performed for 20 minutes at room temperature. The 
sections were treated with 10% normal goat serum for 15 minutes and labeled with 1; 150 
dilution of secondary antibody [anti-mouse IgG (Fab-specific) biotin conjugated, Sigma, St. 
Louis, MO] for 1 hour at room temperature. The sections were then incubated with 
streptavidin-horse radish peroxidase (Kirkegaard & Perrv' Laboratories. Gaithersburg, MD) for 
30 minutes and subjected to a color reaction with diaminobenzidine (DAB, Kirkegaard & Perry 
Laboratories, Gaithersburg, MD) for 15 minutes. After 15 minutes incubation, the sections 
were counterstained with Shandon's hematoxylin for 1 minute and mounted. 
Data analysis 
Two scoring systems were applied to 5 independent areas on each slide. The first 
assessment was to evaluate the level of gene expression on a per cell basis. Subjective scoring 
of signal intensity was scaled according to the color reaction: 0 = no chromogen staining; 1 = 
pale blue; 2 = blue to purple; 3 = dark purple. Another criterion for the scoring system was the 
percentage of positive cells identified in the first evaluation. Subjective scoring of positive cells 
was as follows: 0 = no positive cells; 1 = 1 to 30% of cells positive; 2 = 30% to 70% positive 
cells; 3 = > 70% of cells positive. The mean of each slide was calculated from 5 independent 
observations in a given sample. The mean of a given group was an average of the individual 
tissue mean with standard error of mean. 
An ANOVA test was used to evaluate the effects of M. aviiun subsp. paratuberculosis 
infection on the expression of the APC genes in comparison to negative control tissues. 
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Results 
Results from this study indicate that cells in ileal tissues from cattle with paratuberculosis 
expressed significantly (P< 0.05) more mRNA for APC specific genes, except TNF-a, than 
cells of paratuberculosis-free control animals (Figures 1 and 2). The most dramatic differences 
in cytokine gene expression per cell were observed for IL- la and IFN-y (Figure 2). 
Expression levels of IL-ip and IL-6 genes in paratuberculosis-positive cattle were also 
significandy higher (P< 0.05) than that of paratuberculosis-free control animals but not as 
dramatic as IL-la and IFN-y (Figure 2). The same pattern was observed in results for the 
number of cells that expressed given cytokine genes (Figure 3). In this regard. IL- la was 
again the most prominent cytokine, a greater number of cells in the ileum of paratuberculosis-
positive cattle expressed IL-la than in the ileum of paratuberculosis-free cattle. Interferon-y 
and IL-6 were also expressed in more cells of paratuberculosis-positive cattle than 
paratuberculosis-free animals. In the case of TNF-a, however, a similar number of cells in 
both groups of animals expressed the cytokine mRNA (Figure 3). The results of cytokine 
expression in ileal tissues indicate that among cows naturally infected with M. avium subsp. 
paratuberculosis, IL-la and IRM-y were the cytokines expressed to the greatest extent and may 
be associated with manifesting the disease. Other cytokines. IL-lp and IL-6 were also 
expressed significantly greater in paratuberculosis positive cattle but less than IL-la and 
IFN-y. One of the APCs. TNF-a. was not upregulated in pathophysiology of in the clinical 
stages of paratuberculosis. 
The number of immune cells in the ileum of paratuberculosis-positive cattle was very 
different from that of the paratuberculosis-free control cattle (Figure 4). We found that the 
macrophage was the predominant immune cell in the ileum of paratuberculosis-positive animals 
(Figure 5). In contrast, neutrophils were the predominant cell type in ileum of the 
paratuberculosis-free control cattle. The total number of immune cells in the ileum of 
paratuberculosis-positive cattle was slightly higher than that of the paratuberculosis-free control 
cattle. 
Discussion 
In the present study, it was found that infection with M. avium subsp. paratuberculosis 
substantially increased expression of IL-la, IL-ip, IL-6. and IFN-y genes in sections of ileal 
tissues taken from infected cows. Mycobacterial infection tends to be a chronic disease. 
Similar to other mycobacterial diseases, in subclinic^ stages of paratuberculosis. cell-mediated 
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immunity dominates the host immune response. However, in later stages, the humoral 
immune response takes over and may progress to an anergic state (10, 37). The anergic state is 
mediated by CDS"^ T cell subsets but mycobacteriostatic effects are mediated by CD4'' T cells 
(10-12, 29, 39, 46). This change in immune status may be mediated by a group of 
glycoproteins called cytokines. Cytokines have been extensively studied and are currently 
categorized into two major groupings according to the subset of T helper cells (Th 1 and Th2) 
which are responsible for their secretion (18, 28. 38.42). The cytokines secreted by Thl cells 
are IL-1. IL-2, IFN-y, and TNF-a in contrast to Th2 type cytokines such as IL-4. IL-5, and 
IL-6 (28). It is known that the suppressive effects of CDS* T cells are mediated by Tti2 type 
cytokines such as IL-4 and IL-6. Interestingly, uncharacterized high molecular weight 
mycobacterial cellular fractions (> 200 kDa) induce secretion of IL-4 and IL-6 while they 
suppress TNF-a, IL-2 and IP^-y secretion in human CD8" T cell cultures (39). Even though 
it is believed that Thl cytokines have a more important role in keeping mycobacterial infection 
both subsets are necessary for total immunity (15, 47). 
Among the APC genes that we evaluated, e.xpression of IL-1 a and IFN-y was the most 
pronounced. Monocytes from cattle that were naturally infected with M. avium siibsp. 
pciraiiiberculosis constitutively secreted more than 10 times the amount of IL-1 in comparison 
to cells from non-infected cattle (24). In a human study, peripheral blood mononuclear cells 
(PBMC) from tuberculoid leprosy, lepromatous leprosy and healthy individuals all produced 
Thl type cytokines including IFN-y when stimulated with a variety of mycobacteria (29). 
Usually, Thl cells function to prime or activate phagocytic cells by producing immunologically 
potent cytokines (21). In mycobacterial infection, T-cell derived IFN-y may be priming 
macrophages so these macrophages are able to secrete higher amounts of chemotatic molecules 
(19. 20). Consequently, more immune cells may accumulate at the site of infection. In 
addition. IFN-y may upregulate the expression of endothelial cell adhesion molecules thereby 
increasing the extravasation of inflammatory cells from the blood stream to the infection sites 
(31). This may explain the extremely high number of macrophages noted in the ileum of 
paratuberculosis-positive cattle in this experiment. Other studies indicate that recombinant 
IFN-y may enhance phagocytosis of intracellular pathogens. Pretreatment of bovine 
monocytes with recombinant bovine IFN-y (rbIFN-y) enhances their in vitro phagocytosis of 
iVI. civiuin siibsp. pciratiiberciilosis (48). It has been shown that IFN-y activates resting 
macrophages to kill phagocytosed mycobacteria through TNF-a induced reactive nitrogen 
intermediates (16, 20). The mycobacterium infected monocytes did not produce nitric oxide 
constitutively unless treated with either rIFN-yor rIFN-yplus LPS (48). 
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In contrast to IL-la and IFN-y, the difference in TNF-a expression in ileal tissues between 
paratuberculosis positive and negative animals was negligible. It has been reponed that 
treatment with recombinant cytokines such as IL-1, IL-3, IL-6 and TNF-a alone had no effect 
on killing of M. tuberculosis in vitro (14). But in combination with IFN-7, TNF-a and some 
vitamins (e.g., calcitriol and retinoic acid) can reduce the number of the tubercle bacilli in 
infected macrophages (14, 32, 34, 43, 44). Flesch and Kaufmann reported that IFN-y 
stimulated bone marrow derived macrophages were resistant to subsequent infection with M. 
bovis but IL-4 and TNF treatment failed to inhibit mycobacterial growth (19. 20. 22). 
However, macrophages that were already infected with mycobacteria responded to IL-4 and 
suppressed bacilli growth (15, 19, 20). 
These results imply that the timing of cytokine action is crucial to the success of the 
immunological modulators keeping infection in check. Several papers have demonstrated the 
direct mycobacteriostatic effect of TNF-a (43, 44). At high doses (1000 and 4000 lU/ml) of 
rTNF-a, macrophages can suppress the intracellular growth of M. avium subsp. 
paratuberculosis but at moderate doses (10 and 100 lU/ml) of TNF. the bacilli grow better 
(36). Bermudez and Young showed that TNF-a can activate the in vitro inhibition of 
intracellular multiplication of M. avium complex (8). Kindler et al. further defined a role for 
TNF-a in mycobactericidal activity by showing that anti-TNF treated mice have increased 
viable bacterial counts in their tissues after infection with BCG (23). In addition, it has been 
shown that monocytes from patients with chronic tuberculosis usually produce much less TNF 
compared to the monocytes of healthy individuals (40). In contrast, treatment of M. 
tuberculosis or M avium infected human macrophages with recombinant IL-1 (3 and IL-6, did 
not affect mycobactericidal activity and in the case of M. avium, actually increased growth of 
the bacteria (13, 14, 17, 43, 44). IL-la is also known to deactivate macrophages and thereby 
enhance intracellular growth of mycobacteria (44). Monocytes and subsets of lymphocytes 
produce IL-6 in M. avium infection, however, the function of IL-6 in mycobacterial infection is 
believed to antagonize the immune function of TNF (7. 9). 
In conclusion, we detected high levels of expression of IL-la. IL- Ip, IL-6 and IFN-y in 
the ileal tissues of M. avium subsp. paratuberculosis infected cattle. Although cattle were in 
the clinical stages of disease when tissues were taken the proinflammator\' cytokine. TNF-a, 
was not induced by the infection with the bacteria. Based on these observations, we postulate 
that the constitutively high expre.ssion of IL-1 induces IL-6 secretion. The high level of IL-6 
may in turn suppress cell-mediated immune responses exerted by IFN-y and TNF-a. The 
result of these effects on cytokine production and immune regulation is the chronic infection of 
cattle with paratuberculosis. 
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Figure 1. Gene expression ofTNF-a and IFN-y specific mRNA expression is detected by in 
situ hybridization in ileal tissues of Mycobacterium avium subsp. paraiuberculosis infected 
(left) and non-infected (right) cattle. Hybridized cells are stained with alkaline phosphatase and 
NBT/BCIP substrate (magnification = lOOx). 1 = Ileal tissues from paratuberculosis negative 
cattle, detected for TNF-a mRNA; 2 = Ileal tissues from paratuberculosis positive cattle, 
detected for TNF-a mRNA; 3 = Ileal tissues from paratuberculosis negative cattle, detected for 
IFN-y mRNA; 4 = Ileal tissues from paratuberculosis positive cattle, detected for IFN-y 
mRNA. 
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Figure 2. Cytokine gene expression in ileal tissues of Mycobacterium avium subsp. 
paratuberculosis infected (paratuberculosis positive, n = 7) and non-infcted (paratuberculosis 
negative n = 8) cattle. Level of gene expression was measured by the intensity of cytokine 
gene expression per cell. Subjective scoring of signal intensity was scaled according to the 
color reaction: 0 = no chromogen staining; 1 = pale blue; 2 = blue to purple; 3 = dark purple. 
* means statistically significant difference between paratuberculosis positive and negative 
animals (P< 0.05). 
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Figure 3. Relative amount of cells that expressed acute phase cytokine gene in ileal tissues of 
Mycobacterium avium subsp. paratuberculosis infected (paratuberculosis positive, n = 7) and 
non-infected (paratuberculosis negative n = 8) cattle. Positive cells are cells that hybridized 
with a given cytokine RNA probe thus stained with NBT/BCIP. Subjective scoring of positive 
cells was scaled according to the number of stained cells: 0 = no positive cells: 1 = 1 to 30% of 
cells positive; 2 = 30 to 70% positive cells: 3 = > 70% of cells positive. 
* means statistically significant difference between paratuberculosis positive and negative 
animals (P< 0.05). 
84 
;.A '. • -v^ 
•..v-*v=> 
k,.^»- :.*v .•?•;, • 
5P.'T 
.:i C/ , • . •-*- 7- i*.-. 
••k". 
»•; '.* 
7^^ "i 
« 
'  \ -
;2: 
1!^ 
, V*' 
Figure 4. Photomicrographs of bovine ileal tissues stained with either monoclonal mouse anti-
CD68 for macrophages or goat anti-mouse IgG (Fab specific) for neutrophils (magnification = 
lOOx). 1 = Ileal tissues from paratuberculosis negative cattle, detected for neutrophils; 2 = Ileal 
tissues from paratuberculosis positive cattle, detected for neutrophils; 3 = Ileal tissues from 
paratuberculosis negative cattle, detected for macrophages; 4 = Ileal tissues from 
paratuberculosis positive cattle, detected for macrophages. 
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Figure 5. Percentage of neutrophils and macrophages in ileal tissues of Mycobacterium avium 
subsp. paratuberculosis infected (paratuberculosis positive, n = 7) and non-infected 
(paratuberculosis negative, n = 8) cattle. 
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GENERAL CONCLUSIONS 
Cytokines are small molecular weight glycoproteins secreted by a variety of cells that act as 
signal mediators in immune systems (16, 22). The immune system combined with the 
neurologic system maintains homeostasis of a host from environmental assaults such as an 
infectious disease, parasitic disease, neoplastic disease, trauma, and psychological stress. An 
inflammatory response is nature's way of organisms to cope with various biological stresses, 
and the responses are mediated by cytokines such as interleukin-1 (IL-1), IL-6, interferons 
(II^s) and tumor necrosis factor (TNF) (23, 35). These inflammatory responses may 
accompany fever, loss of appetite, and lean muscle loss (6, 16, 23). Cytokines activate 
immune cells to secrete other immune mediating materials, engulf invading foreign substances, 
neutralize toxins, and to express adhesion mediating receptors. In addition, cytokines activate 
endothelial cells to express cell adhesion molecules such as intercellular adhesion molecule 
(ICAM), epithelial adhesion molecule (ECAM) and vascular adhesion molecule (VC.\M), to 
facilitate immune cell infiltration to the target tissue (9, 29). Among the stimulators of cytokine 
induction, bacteria and their products are well-known. Endotoxin, has been known to be a 
potent inducer of the immune response that activates immune cells to proliferate and produce 
immune mediators including cytokines, lipid metabolites and radical oxygen metabolites (16, 
35). Sepsis, caused by infection of microorganisms or their metabolites is still one of the 
leading causes of death (7. 13, 22, 36). Although endotoxin triggers the immune response 
against Gram negative bacterial infections, the pathophysiology of the response is mediated by 
immune mediators such as cytokines (22). 
Neutrophils are known to be the primary defense cells involved in clearing invading 
microorganisms (11). During infection, neutrophils phagocytose and kill invading 
microorganisms by a series of bactericidal substances such as reactive oxygen metabolites, 
reactive nitrogen metabolites, and lytic enzymes including elasta.se. collagenase and lysozyme 
(II). .Activated neutrophils also synthesize and secrete many cytokines and chemokines to 
induce inflammation along with bactericidal substances that include defensins (10, 12, 14, 15. 
37. 38). In the first study, we tested a new methodology that can detect bovine neutrophils 
more accurately, cost effectively, and faster than any other conventional method. This 
technique can be applied to neutrophil detection in bovine tissues. 
Coliform mastitis, caused by Gram-negative bacteria, e.g., Escherichia coli, has a big 
impact on dairy farmers, even though it can be controlled by the natural defenses and 
conventional preventive methods (5, 8, 18). The actual inflammation inducing agents are 
either/both endotoxin or/and the immune response mediators known as cytokines which 
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include tumor necrosis factor (TNF), interieukin-l (IL-1). IL-6, and IFN-y(5, 21. 24, 25. 31, 
33. 34). In the second study, we detected signs of coliform mastitis from E. coli infected cows 
including increased rectal temperature, somatic ceil count, bacteria shedding, and TNF-a 
secretion in milk from the challenged quaner. Levels of mRNA for all cytokines studied 
increased as the mastitis episode progressed. IL-1 a and TNF-a were induced very rapidly in 
tissues with mild mastitis (over 70% of the severe group's expression) and were higher in 
tissues with severe mastitis than the other cytokines. IL-1 (3, IL-6 and IFN-y e.xpression in the 
mild mastitic tissues, however, were less than 50% of that of the severe mastitic tissues. IL-6 
was a slower starter and continuously increased even in severe mastitic tissues. In coliform 
mastitis, IL-1 a and TNF-a may be the pivotal first cytokines inducing inflammation of 
infected mammary glands, and IL-6 may counteract the progress of inflammation. 
The third study was conducted to understand the role of the adhesion molecule, CD 18. in 
acute lung disease caused by a Gram-negative bacterium, Pasieiirelki hciemolytica. Beta, (po-
integrins mediate tight adhesion of leukocytes onto endothelial membranes of inflamed tissues 
and are composed of alpha (CDI la, b, c & d) and beta (CD18) subunit heterodimers that also 
transduce signals (1,2, 17, 19, 20, 26-28, 30, 32). Ba.sal cytokine gene e.xpression per cell 
was higher in the lungs of CD 18" cows than those of CD 18" cows. At 2 h post-inoculation 
(PI), levels of gene expression between CD 18"' and CD 18" cattle were not significantly 
different. At 4 h PI, the lungs of CD 18'' cattle expressed stronger signals and demonstrated 
increased expression of all APC genes, except IL-1 (3, than that of the CD 18" cattle. The rate of 
neutrophil infiltration into the lungs of the CD 18" cattle after challenge with P. haemolyiica was 
significantly higher than that of CD 18"' cattle. The higher percentage and faster infiltration of 
immune cells seen in the CD 18" animals may be a compensatory mechanism to cope with the 
immune malfunction of the host. These data suggest that p,-integrins contribute to the signal 
transduction necessary for the induction of APC gene expression, especially for IFN-y and 
TNF-a gene expression as a consequence of P. hciemolytica infection. Those two 
experiments were conducted to understand the relationship between acute Gram-negative 
bacterial infections and cytokine gene expression in host tissues. 
The fourth experiment studied the effect of a Gram-positive, acid fast bacterium. 
Mycobacterium paratuberciilosis, infection in bovine ileal tissues on cytokine gene expression 
as a chronic disease model. Pathogenic mycobacteria can survive inside macrophages and 
establish chronic infections, granulomas, and lead to fibrosis of tissues (3, 4). We could detect 
high numbers of monocyte infiltration into the ileal tissues from paratuberculosis positive 
animals. Among the cytokines we tested, IL-la, IL-1 (3, IL-6, and IFN-y were expressed 
significantly more in paratuberculosis positive animals than in paratuberculosis negative 
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animals. The expressions of TNF-a, however, were not different between paratuberculosis 
positive and negative animals. Based on the observations, we postulate that the constitutively 
high expression of EL-1 induces IL-6 secretion. The high level of IL-6 may in turn suppress 
cell-mediated immune responses exened by IFN-y and TNF-a. The results of these effects on 
cytokine production and immune regulation is the chronic infection of cattle with 
paratuberculosis. 
In summary, we found that there are differences between acute and chronic diseases caused 
by Gram-negative and Gram-positive bacteria respectively, in terms of the leukocyte subsets 
involved and cytokine expression. The kinetics of each cytokine are regulated differently. 
However, there is a common theme in the expression of cytokines as an example, the high 
expression of IL-la and TNF-a in acute infections and IL-la and IFN-y involvement in 
chronic disease. These studies suggest that the therapeutic use of soluble cytokine receptors 
would aid in the amelioration of inflammatory reactions. 
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